{
  "cells": [
    {
      "cell_type": "code",
      "execution_count": 1,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "1AfSrrXBI8oi",
        "outputId": "e2a2a86e-19d1-4cdc-e64b-0aa550f87f27"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Drive already mounted at /content/drive; to attempt to forcibly remount, call drive.mount(\"/content/drive\", force_remount=True).\n"
          ]
        }
      ],
      "source": [
        "from google.colab import drive\n",
        "drive.mount('/content/drive')"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 2,
      "metadata": {
        "id": "UWSHSonXlTeG"
      },
      "outputs": [],
      "source": [
        "# packages\n",
        "import torch\n",
        "from transformers import AutoModelForCausalLM, AutoTokenizer\n",
        "\n",
        "# from goatools import obo_parser"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": null,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "M9sSOV2PXqOJ",
        "outputId": "f34cbcd6-05e3-4855-af0f-2d9c450085cc"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Requirement already satisfied: biopython in /usr/local/lib/python3.11/dist-packages (1.85)\n",
            "Requirement already satisfied: numpy in /usr/local/lib/python3.11/dist-packages (from biopython) (1.26.4)\n",
            "Gene(433766)\n",
            "  Symbol          : Trim63\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : tripartite motif-containing 63\n",
            "  Also Known As   : MuRF1, RF1, Rnf28\n",
            "  In-text Name    : Muscle-specific RING finger protein-1\n",
            "  Occurrences     : ['In particular, atrogenes are thought to be important for protein loss. Muscle-specific RING finger protein-1 (MuRF1) is an E3 ubiquitin ligase selectively expressed in cardiac and skeletal muscles. This protein is upregulated during skeletal muscle atrophy and is able to control sarcomere muscle protein degradation.', 'The first muscle-specific ubiquitin ligases that were discovered to have a role in muscle loss were Atrogin-1/MAFbx and muscle ring finger-1 (MuRF1). Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions.', 'Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy.', 'It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy.', 'Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy. During atrophy, other E3s are produced in smaller quantities, including Trim32, a ligase important for actin, tropomyosin, and troponins degradation.', 'For example, the inhibition of some specific muscle proteins such as MAFbx or Foxo, ATF4, Gadd45a, p21, and MEKK4 transcription factors can avoid the loss of muscle mass without leading to a hypertrophic condition. Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice.', 'Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice. As an example, MG132 proteasome inhibitor can prevent muscle atrophy associated with muscle disuse.', 'Therefore, the administration of protein supplements or compounds able to stimulate protein synthesis could be useful in the prevention of atrophy. For instance, ursolic acid stimulates muscle hypertrophy and reduces the expression of MuRF-1 in soleus and extensor digitorum longus (EDL) muscle of chronic kidney disease mice. It also reduced myostatin and insulin-like growth factor-binding protein 3 (IGFBP3) in dexamethasone-treated C2C12 cell lines.', 'Identification of the MuRF1 Skeletal Muscle Ubiquitylome Through Quantitative Proteomics', 'Skeletal muscle in MuRF1 null mice is not spared in low-gravity conditions, indicating atrophy proceeds by unique mechanisms in space']\n",
            "There are 10 occurrences (each are AT MOST 3-setences long SO MAX of 30 sentences in total) of 433766:Muscle-specific RING finger protein-1.\n",
            "\n",
            "Gene(77891)\n",
            "  Symbol          : Ube2s\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : ubiquitin-conjugating enzyme E2S\n",
            "  Also Known As   : 0910001J09Rik, 6720465F12Rik, E2-EPF\n",
            "  In-text Name    : ubiquitin protein ligases\n",
            "  Occurrences     : ['In skeletal muscle, the ubiquitin-proteasome system appears to play an important role in muscle loss. Indeed, a decrease in muscle mass may be associated with an upregulation of some ubiquitin-conjugating enzymes (E2) and some ubiquitin protein ligases (E3). The first muscle-specific ubiquitin ligases that were discovered to have a role in muscle loss were Atrogin-1/MAFbx and muscle ring finger-1 (MuRF1).']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 77891:ubiquitin protein ligases.\n",
            "\n",
            "Gene(67731)\n",
            "  Symbol          : Fbxo32\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : F-box protein 32\n",
            "  Also Known As   : 4833442G10Rik, ATROGIN1, Gm20361, MAFbx\n",
            "  In-text Name    : Atrogin-1\n",
            "  Occurrences     : ['Indeed, a decrease in muscle mass may be associated with an upregulation of some ubiquitin-conjugating enzymes (E2) and some ubiquitin protein ligases (E3). The first muscle-specific ubiquitin ligases that were discovered to have a role in muscle loss were Atrogin-1/MAFbx and muscle ring finger-1 (MuRF1). Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I.', 'Glucocorticoid-induced muscle atrophy relies on an increase in protein catabolism and reduced protein synthesis. The action of glucocorticoids on protein degradation is mediated by atrogenes such as FOXO, Atrogin-1, and MuRF-1. In particular, the myosin heavy chain contractile proteins are the most affected.', 'The most studied targets belong to the anabolic pathways and to the ubiquitin-proteasome system. For example, the inhibition of some specific muscle proteins such as MAFbx or Foxo, ATF4, Gadd45a, p21, and MEKK4 transcription factors can avoid the loss of muscle mass without leading to a hypertrophic condition. Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors.', 'The production of free radicals consequently determines an increase in protein catabolism. For example, vitamin C deficiency has been shown to cause muscle atrophy in mice, associated with high expression of MAFbx and MuRF1 and hyperproduction of ROS. Vitamin E has been described as an antioxidant able to prevent hindlimb immobilization-induced muscle atrophy in rats.', 'Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy']\n",
            "There are 5 occurrences (each are AT MOST 3-setences long SO MAX of 15 sentences in total) of 67731:Atrogin-1.\n",
            "\n",
            "Gene(69807)\n",
            "  Symbol          : Trim32\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : tripartite motif-containing 32\n",
            "  Also Known As   : 1810045E12Rik, 3f3, BBS11, Zfp117\n",
            "  In-text Name    : Trim32\n",
            "  Occurrences     : ['However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy. During atrophy, other E3s are produced in smaller quantities, including Trim32, a ligase important for actin, tropomyosin, and troponins degradation. Nevertheless, Trim32 knockout mice are sensitive to atrophy and show an inability to recover muscle mass after atrophy.', 'During atrophy, other E3s are produced in smaller quantities, including Trim32, a ligase important for actin, tropomyosin, and troponins degradation. Nevertheless, Trim32 knockout mice are sensitive to atrophy and show an inability to recover muscle mass after atrophy. Another E3 ubiquitin ligase relevant to atrophy is TRAF6, which promotes the union of Lys63-bound polyubiquitin chains to its target proteins.', 'Ubiquitylation by Trim32 causes coupled loss of desmin Z-bands, and thin filaments in muscle atrophy']\n",
            "There are 3 occurrences (each are AT MOST 3-setences long SO MAX of 9 sentences in total) of 69807:Trim32.\n",
            "\n",
            "Gene(68350)\n",
            "  Symbol          : Mul1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : mitochondrial ubiquitin ligase activator of NFKB 1\n",
            "  Also Known As   : 0610009K11Rik, Gide\n",
            "  In-text Name    : E3 ubiquitin ligase\n",
            "  Occurrences     : ['Nevertheless, Trim32 knockout mice are sensitive to atrophy and show an inability to recover muscle mass after atrophy. Another E3 ubiquitin ligase relevant to atrophy is TRAF6, which promotes the union of Lys63-bound polyubiquitin chains to its target proteins. Muscle-specific TRAF6 knockout mice have low amounts of polyubiquitylated proteins in starving muscles.', 'The E3 ubiquitin ligase TRAF6 intercedes in starvation-induced skeletal muscle atrophy through multiple mechanisms', 'Knockdown of the E3 ubiquitin ligase UBR5 and its role in skeletal muscle anabolism']\n",
            "There are 3 occurrences (each are AT MOST 3-setences long SO MAX of 9 sentences in total) of 68350:E3 ubiquitin ligase.\n",
            "\n",
            "Gene(22034)\n",
            "  Symbol          : Traf6\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : TNF receptor-associated factor 6\n",
            "  Also Known As   : 2310003F17Rik, C630032O20Rik\n",
            "  In-text Name    : TRAF6\n",
            "  Occurrences     : ['Another E3 ubiquitin ligase relevant to atrophy is TRAF6, which promotes the union of Lys63-bound polyubiquitin chains to its target proteins. Muscle-specific TRAF6 knockout mice have low amounts of polyubiquitylated proteins in starving muscles. TRAF6-mediated ubiquitylation is essential for the activation of different factors, such as JNK, AMPK, FoxO3, and NFkappaB, which, in turn, are important for atrogin-1 and MuRF1 expression (Figure 1).', 'Muscle-specific TRAF6 knockout mice have low amounts of polyubiquitylated proteins in starving muscles. TRAF6-mediated ubiquitylation is essential for the activation of different factors, such as JNK, AMPK, FoxO3, and NFkappaB, which, in turn, are important for atrogin-1 and MuRF1 expression (Figure 1).', 'Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice']\n",
            "There are 3 occurrences (each are AT MOST 3-setences long SO MAX of 9 sentences in total) of 22034:TRAF6.\n",
            "\n",
            "Gene(13346)\n",
            "  Symbol          : Des\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : desmin\n",
            "  Also Known As   : desmin\n",
            "  In-text Name    : desmin\n",
            "  Occurrences     : ['These proteins are generally localized at the level of the Z disk of the sarcomere, where they initiate the proteolytic cleavage of muscle proteins that make up the sarcomere. Calpain has been shown to initiate in vitro the digestion of individual myofibrillar proteins, including desmin, filamen, protein C, tropomyosin, troponin T, troponin I, titin, nebulin, vimentin, gelsolin, and vinculin. Due to its proteolytic properties, calpain appears to be involved in muscle atrophy.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 13346:desmin.\n",
            "\n",
            "Gene(12380)\n",
            "  Symbol          : Cast\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : calpastatin\n",
            "  Also Known As   : calpastatin\n",
            "  In-text Name    : calpastatin\n",
            "  Occurrences     : ['Due to its proteolytic properties, calpain appears to be involved in muscle atrophy. In vivo studies have also shown that in transgenic mice overexpressing calpastatin, a calpain inhibitor, the hindlimb unloading (HU)-induced atrophy was reduced by 30%. Furthermore, the shift of myofibrillar myosin from slow-to-fast isoforms was avoided.', '[Calpain and calpastatin--structure and function]', 'Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse']\n",
            "There are 3 occurrences (each are AT MOST 3-setences long SO MAX of 9 sentences in total) of 12380:calpastatin.\n",
            "\n",
            "Gene(12333)\n",
            "  Symbol          : Capn1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : calpain 1\n",
            "  Also Known As   : Capa-1, Capa1, mu-calpin\n",
            "  In-text Name    : calpain 1\n",
            "  Occurrences     : ['These results show that calpain has an important role in muscle atrophy due to hindlimb suspension and sarcopenia. Another study highlighted the role of calpain 1 in the ubiquitin-proteasome pathway and in the anabolic processes mediated by Akt-mTOR-p70S6K and MAPK-Erk (p90RSK) signaling. PD150606, a calpain inhibitor, was tested for its effect in three-day hindlimb-suspended (HS) rat muscle and compared with those found in HS untreated animals.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 12333:calpain 1.\n",
            "\n",
            "Gene(29153)\n",
            "  Symbol          : Capn1\n",
            "  Organism        : Rattus norvegicus\n",
            "  Full Name       : calpain 1\n",
            "  Also Known As   : CANP 1, muCANP\n",
            "  In-text Name    : calpain-1\n",
            "  Occurrences     : ['PD150606, a calpain inhibitor, was tested for its effect in three-day hindlimb-suspended (HS) rat muscle and compared with those found in HS untreated animals. The calpain inhibitor reduced the activation of calpain-1 mRNA expression, reduced activation of MAFbx mRNA, and reduced protein ubiquitination and eEF2 mRNA expression, again supporting the role of calpain in inducing muscle atrophy.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 29153:calpain-1.\n",
            "\n",
            "Gene(20655)\n",
            "  Symbol          : Sod1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : superoxide dismutase 1, soluble\n",
            "  Also Known As   : B430204E11Rik, Cu/Zn-SOD, CuZnSOD, Ipo-1, Ipo1, SODC, Sod-1\n",
            "  In-text Name    : SOD1\n",
            "  Occurrences     : ['Autophagy hyperactivation has been found to contribute to muscle loss in various conditions, such as cancer cachexia, fasting, sepsis, chemotherapy, disuse, and denervation. Oxidative stress was generated by a mutant superoxide dismutase protein (SOD1-G93A) expression able to cause muscle atrophy by activating autophagy (in particular LC3, a protein that contributes to the formation autophagosome) in SOD1-G93A transgenic mice model of ALS, suggesting that the modulation of the autophagic process can be a promising therapeutic intervention to counteract muscle atrophy connected with oxidative stress.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 20655:SOD1.\n",
            "\n",
            "Gene(10533)\n",
            "  Symbol          : ATG7\n",
            "  Organism        : Homo sapiens\n",
            "  Full Name       : autophagy related 7\n",
            "  Also Known As   : APG7-LIKE, APG7L, GSA7, SCAR31\n",
            "  In-text Name    : Atg7\n",
            "  Occurrences     : ['Although few data are available regarding the role of autophagy in muscle atrophy, the inactivation of muscle-specific genes that codify for autophagy-related proteins demonstrates the function of autophagy in muscle homeostasis. For example, Atg7-null mice exhibit muscle atrophy. In fact, the removal of Atg7, an E1 enzyme of the autophagic process, causes activation of the unfolded protein response, which in turn triggers the degeneration of myofibers; this leads to inhibition of autophagosome formation, with consequent oxidative stress and accumulation of polyubiquitylated proteins.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 10533:Atg7.\n",
            "\n",
            "Gene(74244)\n",
            "  Symbol          : Atg7\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : autophagy related 7\n",
            "  Also Known As   : 1810013K23Rik, Agp7, Apg7l, Atg7l, Gm21553\n",
            "  In-text Name    : Atg7\n",
            "  Occurrences     : ['For example, Atg7-null mice exhibit muscle atrophy. In fact, the removal of Atg7, an E1 enzyme of the autophagic process, causes activation of the unfolded protein response, which in turn triggers the degeneration of myofibers; this leads to inhibition of autophagosome formation, with consequent oxidative stress and accumulation of polyubiquitylated proteins. Another example was observed in mice with muscle-specific removal of Atg5, a component of the autophagic mechanism.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 74244:Atg7.\n",
            "\n",
            "Gene(11793)\n",
            "  Symbol          : Atg5\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : autophagy related 5\n",
            "  Also Known As   : 2010107M05Rik, 3110067M24Rik, Apg5l, Atg5l, Paddy\n",
            "  In-text Name    : Atg5\n",
            "  Occurrences     : ['In fact, the removal of Atg7, an E1 enzyme of the autophagic process, causes activation of the unfolded protein response, which in turn triggers the degeneration of myofibers; this leads to inhibition of autophagosome formation, with consequent oxidative stress and accumulation of polyubiquitylated proteins. Another example was observed in mice with muscle-specific removal of Atg5, a component of the autophagic mechanism. Although there are few studies regarding autophagy in the skeletal muscle of elderly people, some studies have shown that abnormal regulation of autophagy could contribute to sarcopenia, which is a loss of muscle mass and function that occurs as a result of the aging process.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 11793:Atg5.\n",
            "\n",
            "Gene(12043)\n",
            "  Symbol          : Bcl2\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : B cell leukemia/lymphoma 2\n",
            "  Also Known As   : Bcl-2, C430015F12Rik, D630044D05Rik, D830018M01Rik\n",
            "  In-text Name    : BCL2\n",
            "  Occurrences     : ['Mitochondrial apoptosis-associated atrophy can be the result of sarcopenia, disuse (i.e., immobilization and denervation), or specific myopathies (i.e., muscular dystrophy). The BCL2 family, involving pro- and anti-apoptotic proteins, plays a role in mitochondrial apoptotic signaling.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 12043:BCL2.\n",
            "\n",
            "Gene(12028)\n",
            "  Symbol          : Bax\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : BCL2-associated X protein\n",
            "  Also Known As   : BAX\n",
            "  In-text Name    : BAX\n",
            "  Occurrences     : ['During muscle atrophy due to disuse (denervation, immobilization, hindlimb unloading), elevated total and mitochondrial BAX, altered total BCL2, and CASP9 activation are observed. Importantly, Bax- and Bax/Bak-knockout attenuates muscle atrophy and a number of the mitochondrial apoptotic changes that occur with denervation.', 'During muscle atrophy due to disuse (denervation, immobilization, hindlimb unloading), elevated total and mitochondrial BAX, altered total BCL2, and CASP9 activation are observed. Importantly, Bax- and Bax/Bak-knockout attenuates muscle atrophy and a number of the mitochondrial apoptotic changes that occur with denervation. Mechanistic studies in vitro demonstrated that elevation of miR-142a-5p suppressed mitofusin 1 (MFN1), leading to elevated total BAX:BCL2, CASP9, and CASP3 activation.']\n",
            "There are 2 occurrences (each are AT MOST 3-setences long SO MAX of 6 sentences in total) of 12028:BAX.\n",
            "\n",
            "Gene(67414)\n",
            "  Symbol          : Mfn1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : mitofusin 1\n",
            "  Also Known As   : 2310002F04Rik, 6330416C07Rik, D3Ertd265e, HR2, mKIAA4032\n",
            "  In-text Name    : mitofusin 1\n",
            "  Occurrences     : ['Importantly, Bax- and Bax/Bak-knockout attenuates muscle atrophy and a number of the mitochondrial apoptotic changes that occur with denervation. Mechanistic studies in vitro demonstrated that elevation of miR-142a-5p suppressed mitofusin 1 (MFN1), leading to elevated total BAX:BCL2, CASP9, and CASP3 activation.', 'Denervation drives skeletal muscle atrophy and induces mitochondrial dysfunction, mitophagy and apoptosis via miR-142a-5p/MFN1 axis']\n",
            "There are 2 occurrences (each are AT MOST 3-setences long SO MAX of 6 sentences in total) of 67414:mitofusin 1.\n",
            "\n",
            "Gene(2475)\n",
            "  Symbol          : MTOR\n",
            "  Organism        : Homo sapiens\n",
            "  Full Name       : mechanistic target of rapamycin kinase\n",
            "  Also Known As   : FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS\n",
            "  In-text Name    : mammalian target of rapamycin\n",
            "  Occurrences     : ['Muscle atrophy may also be caused by a decline in protein synthesis or impairment of regenerative pathways during disuse or other forms of atrophy. This event can be associated with oxidative stress or with the alteration of the serine/threonine kinase, the mammalian target of rapamycin (mTOR), the principal regulator of protein synthesis by mediating the effects of growth factors. Indeed, under disuse conditions, a decrease in protein synthesis is the result of mTOR inhibition.', 'This event can be associated with oxidative stress or with the alteration of the serine/threonine kinase, the mammalian target of rapamycin (mTOR), the principal regulator of protein synthesis by mediating the effects of growth factors. Indeed, under disuse conditions, a decrease in protein synthesis is the result of mTOR inhibition. Accordingly, in adult rodents, a few days of treatment with rapamycin, a mTORC1 inhibitor, delays skeletal muscle growth.', 'In particular, the myosin heavy chain contractile proteins are the most affected. It is thought that the inhibitory action of glucocorticoids on muscle protein synthesis derives mostly from the inhibition of the mTOR pathway. The glucocorticoid receptor promotes the expression of two genes, codifying for REDD1 and KLF15.', 'REDD1 inhibits the activity of mTOR. Inhibition of mTOR activates KLF15, promoting atrophy. KLEF15 is a transcription factor involved in several metabolic processes in skeletal muscle, for example, in the upregulation of branched-chain aminotransferase 2 (BCAT2), which, in turn, induces the degradation of branched-chain amino acids.', 'Leucine is an essential amino acid able to increase muscle protein synthesis in C2C12 myotubes by activating the mTOR complex and the 4E binding protein-1 (4E-BP1) signaling pathway. This is an intracellular pathway that controls muscle protein synthesis.', 'Indeed, they can assist peptide synthesis and prevent protein breakdown. The parameters ameliorated by BCAAs action were myofiber CSA, muscle force, and contraction, as well as protein synthesis mediated by the mTOR pathway. Accordingly, BCAA supplementation in older people has been found to improve muscle mass and strength.', 'mTOR Signaling in Growth, Metabolism, and Disease', 'mTOR signaling and the molecular adaptation to resistance exercise', 'AMP-activated protein kinase suppresses protein synthesis in rat skeletal muscle through down-regulated mammalian target of rapamycin (mTOR) signaling']\n",
            "There are 9 occurrences (each are AT MOST 3-setences long SO MAX of 27 sentences in total) of 2475:mammalian target of rapamycin.\n",
            "\n",
            "Gene(70790)\n",
            "  Symbol          : Ubr5\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : ubiquitin protein ligase E3 component n-recognin 5\n",
            "  Also Known As   : Edd, Edd1\n",
            "  In-text Name    : UBR5\n",
            "  Occurrences     : ['Recent studies supported a role for UBR5, an E3 ubiquitin ligase, in the anabolic process and recovery from muscle atrophy; thus, the silencing of UBR5 results in skeletal muscle atrophy. The knockdown of UBR5 was found to be associated with reductions in ERK1/2 and Akt phosphorylation, reduction in the level of eIF4e, which is involved in translation initiation, and consequent impairment of protein synthesis.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 70790:UBR5.\n",
            "\n",
            "Gene(67118)\n",
            "  Symbol          : Bfar\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : bifunctional apoptosis regulator\n",
            "  Also Known As   : 3010001A07Rik, 3110001I22Rik, Bar, Rnf47\n",
            "  In-text Name    : beta-AR\n",
            "  Occurrences     : ['An anabolic role was discovered for beta-AR agonists. Indeed, clenbuterol was found to accelerate the recovery from disuse-induced atrophy and spinal and bulbar muscle atrophy.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 67118:beta-AR.\n",
            "\n",
            "Gene(382056)\n",
            "  Symbol          : Crtc1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : CREB regulated transcription coactivator 1\n",
            "  Also Known As   : Mect1, TORC-1, TORC1, mKIAA0616\n",
            "  In-text Name    : TORC1\n",
            "  Occurrences     : ['Indeed, clenbuterol was found to accelerate the recovery from disuse-induced atrophy and spinal and bulbar muscle atrophy. The mechanism seems to involve the stimulation of protein synthesis through the enhancement of TORC1 activation. However, hypertrophy is not always functional since a reduced normalized strength was observed.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 382056:TORC1.\n",
            "\n",
            "Gene(193034)\n",
            "  Symbol          : Trpv1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : transient receptor potential cation channel, subfamily V, member 1\n",
            "  Also Known As   : OTRPC1, TRPV1alpha, TRPV1beta, VR-1, Vr1\n",
            "  In-text Name    : transient receptor potential cation channel, subfamily V, member 1\n",
            "  Occurrences     : ['However, hypertrophy is not always functional since a reduced normalized strength was observed. In addition, nitric oxide (NO) was suggested to play a role in muscle hypertrophy via the activation of the transient receptor potential cation channel, subfamily V, member 1 (TRPV1), causing an increase in intracellular Ca2+ levels and an increase in protein synthesis through TORC1 activation by an unknown mechanism.', 'Capsaicin mimics mechanical load-induced intracellular signaling events: Involvement of TRPV1-mediated calcium signaling in induction of skeletal muscle hypertrophy']\n",
            "There are 2 occurrences (each are AT MOST 3-setences long SO MAX of 6 sentences in total) of 193034:transient receptor potential cation channel, subfamily V, member 1.\n",
            "\n",
            "Gene(19017)\n",
            "  Symbol          : Ppargc1a\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : peroxisome proliferative activated receptor, gamma, coactivator 1 alpha\n",
            "  Also Known As   : A830037N07Rik, Gm11133, PGC-1, PPARGC-1-alpha, Pgc-1alpha, Pgc1, Pgco1, Ppargc1\n",
            "  In-text Name    : PGC-1alpha\n",
            "  Occurrences     : ['Recent studies highlight the possibility that the overexpression of a splice variant of PGC-1alpha, PGC-1alpha4, may induce muscle fiber hypertrophy through the downregulation of myostatin expression and increase in IGF-1 expression. Importantly, PGC-1alpha4 expression was found to be increased in response to exercise.', '(2019) did not find significant changes in MyHC type I or fast MyHC fibers at 3-days of unloading. In addition, the PGC-1alpha transcript and protein were unchanged during the same period. However, it should be underlined that, in contrast to our results, other authors have measured a modification of the MHC already at 24 h.', 'A PGC-1alpha isoform induced by resistance training regulates skeletal muscle hypertrophy', 'The role of alterations in mitochondrial dynamics and PGC-1alpha over-expression in fast muscle atrophy following hindlimb unloading']\n",
            "There are 4 occurrences (each are AT MOST 3-setences long SO MAX of 12 sentences in total) of 19017:PGC-1alpha.\n",
            "\n",
            "Gene(17927)\n",
            "  Symbol          : Myod1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : myogenic differentiation 1\n",
            "  Also Known As   : MYF3, MyoD, Myod-1, bHLHc1\n",
            "  In-text Name    : MyoD\n",
            "  Occurrences     : ['Interestingly, skeletal muscle regeneration is impaired during disuse, likely due to decreased MyoD and myogenin expression and myostatin signaling upregulation.', 'Activation of NF-kappaB has been shown to reduce levels of the MyoD protein. MyoD, also known as myoblast-determining protein 1, is a myogenic transcription factor that plays an important role in regulating muscle differentiation. Activation of NF-kappaB increases the expression of the inducible nitric oxide synthase (iNOS) in muscle cells that sequester HuR (RNA-binding protein) by preventing transcription of MyoD.', 'It would appear that the expression of the ClC1 channel is under nerve control. There are two regulatory pathways proposed: the pathway involving MyoD, belonging to the family of helix-loop-helix transcription factors, and the NFAT signaling pathway involving calcium-dependent calcineurin. Between the two, only the first way seems to be involved during the HU.', 'The eIF2 protein (eukaryotic initiation factor of protein translation) was decreased during HU and restored in HU-ND mice. The ND treatment prevented the alteration in MyoD and Notch-1 expression suggesting the advancement of myogenic stem cell differentiation in response to atrophy. However, despite its action at the protein level, Sol muscle function was not restored after ND treatment.', 'Ghrelin null mice (Ghrl -/-) are more prone to fasting-induced muscle atrophy, particularly in the Gas muscle. In these mice, there is also a reduced expression of the myogenic regulator MyoD and a higher expression of the protein degradation marker MuRF1.']\n",
            "There are 5 occurrences (each are AT MOST 3-setences long SO MAX of 15 sentences in total) of 17927:MyoD.\n",
            "\n",
            "Gene(18033)\n",
            "  Symbol          : Nfkb1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105\n",
            "  Also Known As   : NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105\n",
            "  In-text Name    : Nuclear factor kappa-light-chain-enhancer of activated B cells\n",
            "  Occurrences     : ['Different factors are involved in the signaling pathways leading to atrophy. Nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) is a protein complex that functions as a transcription factor. This plays an important role in regulating the immune response to infections, and its dysfunctions have been linked to cancer, inflammatory processes, autoimmune diseases, viral infections, and diseases of the immune system.', 'This plays an important role in regulating the immune response to infections, and its dysfunctions have been linked to cancer, inflammatory processes, autoimmune diseases, viral infections, and diseases of the immune system. NFkappaB is also expressed in skeletal muscle, where it mediates the effect of inflammatory cytokines, in particular tumor necrosis factor-alpha (TNFalpha), as observed during muscle loss and cachexia. In the inactivated state, NF-KB is present in the cytosol, linked to an inhibitory protein.', 'IKK, in turn, is responsible for IkappaBalpha protein phosphorylation leading to its ubiquitination and degradation in the proteasome. Thus NF-kappaB is available. It has been found that NFkappaB activation in skeletal muscle determines muscle degeneration and inhibits regeneration in dystrophic muscles.', 'Thus NF-kappaB is available. It has been found that NFkappaB activation in skeletal muscle determines muscle degeneration and inhibits regeneration in dystrophic muscles. NF-kappaB can raise the expression of ubiquitin-proteasome system proteins (e.g., MURF1) and/or proinflammatory cytokines, and also chemokines able to contribute to skeletal muscle wasting.', 'It has been found that NFkappaB activation in skeletal muscle determines muscle degeneration and inhibits regeneration in dystrophic muscles. NF-kappaB can raise the expression of ubiquitin-proteasome system proteins (e.g., MURF1) and/or proinflammatory cytokines, and also chemokines able to contribute to skeletal muscle wasting. In fact, it has been observed that the muscle-specific overexpression of IKKbeta in transgenic mice leads to muscle mass loss mediated by the action of the ubiquitin ligase E3 MuRF1.', 'The \"myogenesis\" is the phenomenon that leads to the differentiation and formation of a skeletal muscle fiber, which starts during the first week of embryonic development. NF-kappaB inhibits myogenic differentiation through the accumulation of cyclin D1 and the activation of YinYang1 (YY1), a negative regulator of myogenesis, which works by blocking the synthesis of genes such as actin, creatine kinase, and myosin heavy chain IIb. Activation of NF-kappaB has been shown to reduce levels of the MyoD protein.', 'NF-kappaB inhibits myogenic differentiation through the accumulation of cyclin D1 and the activation of YinYang1 (YY1), a negative regulator of myogenesis, which works by blocking the synthesis of genes such as actin, creatine kinase, and myosin heavy chain IIb. Activation of NF-kappaB has been shown to reduce levels of the MyoD protein. MyoD, also known as myoblast-determining protein 1, is a myogenic transcription factor that plays an important role in regulating muscle differentiation.', 'MyoD, also known as myoblast-determining protein 1, is a myogenic transcription factor that plays an important role in regulating muscle differentiation. Activation of NF-kappaB increases the expression of the inducible nitric oxide synthase (iNOS) in muscle cells that sequester HuR (RNA-binding protein) by preventing transcription of MyoD. Denervation-induced atrophy is related to the upregulation of specific histone deacetylases (HDAC), able to repress a negative regulator of myogenin, with an increase in MuRF1 expression and muscle wasting.', 'Activation of NF-kappaB pathway in Duchenne muscular dystrophy: Relation to age', 'NF-kappaB regulation of YY1 inhibits skeletal myogenesis through transcriptional silencing of myofibrillar genes']\n",
            "There are 10 occurrences (each are AT MOST 3-setences long SO MAX of 30 sentences in total) of 18033:Nuclear factor kappa-light-chain-enhancer of activated B cells.\n",
            "\n",
            "Gene(21926)\n",
            "  Symbol          : Tnf\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : tumor necrosis factor\n",
            "  Also Known As   : DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa, Tnfsf1a, Tnlg1f\n",
            "  In-text Name    : TNFalpha\n",
            "  Occurrences     : ['In the inactivated state, NF-KB is present in the cytosol, linked to an inhibitory protein. A variety of extracellular signals, including TNFalpha, can activate the IK B kinase (IKK) enzyme. IKK, in turn, is responsible for IkappaBalpha protein phosphorylation leading to its ubiquitination and degradation in the proteasome.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 21926:TNFalpha.\n",
            "\n",
            "Gene(18035)\n",
            "  Symbol          : Nfkbia\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha\n",
            "  Also Known As   : Nfkbi\n",
            "  In-text Name    : IkappaBalpha\n",
            "  Occurrences     : ['A variety of extracellular signals, including TNFalpha, can activate the IK B kinase (IKK) enzyme. IKK, in turn, is responsible for IkappaBalpha protein phosphorylation leading to its ubiquitination and degradation in the proteasome. Thus NF-kappaB is available.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 18035:IkappaBalpha.\n",
            "\n",
            "Gene(16150)\n",
            "  Symbol          : Ikbkb\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : inhibitor of kappaB kinase beta\n",
            "  Also Known As   : IKK-2, IKK-B, IKK-beta, IKK2, IKK[b], IKKbeta, NFKBIKB\n",
            "  In-text Name    : IKKbeta\n",
            "  Occurrences     : ['NF-kappaB can raise the expression of ubiquitin-proteasome system proteins (e.g., MURF1) and/or proinflammatory cytokines, and also chemokines able to contribute to skeletal muscle wasting. In fact, it has been observed that the muscle-specific overexpression of IKKbeta in transgenic mice leads to muscle mass loss mediated by the action of the ubiquitin ligase E3 MuRF1. In support of this, it was found that the specific deletion of IKKbeta in skeletal muscle in mice avoided the expression of the MuRF1 gene and consequently prevented atrophy.', 'In fact, it has been observed that the muscle-specific overexpression of IKKbeta in transgenic mice leads to muscle mass loss mediated by the action of the ubiquitin ligase E3 MuRF1. In support of this, it was found that the specific deletion of IKKbeta in skeletal muscle in mice avoided the expression of the MuRF1 gene and consequently prevented atrophy. Despite the mechanisms still not being fully understood, NF-kB also seems to interfere with the IGF1-Akt signaling pathway.', 'Despite the mechanisms still not being fully understood, NF-kB also seems to interfere with the IGF1-Akt signaling pathway. Indeed, it has been noted that conditional IKKbeta knockout mice are resistant to muscle atrophy but demonstrate Akt hyper-phosphorylation. Activation of NF-kB can also generate muscle atrophy by opposing myogenic differentiation.', 'IKKbeta/NF-kappaB activation causes severe muscle wasting in mice']\n",
            "There are 4 occurrences (each are AT MOST 3-setences long SO MAX of 12 sentences in total) of 16150:IKKbeta.\n",
            "\n",
            "Gene(16000)\n",
            "  Symbol          : Igf1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : insulin-like growth factor 1\n",
            "  Also Known As   : C730016P09Rik, Igf-1, Igf-I\n",
            "  In-text Name    : IGF1\n",
            "  Occurrences     : ['In support of this, it was found that the specific deletion of IKKbeta in skeletal muscle in mice avoided the expression of the MuRF1 gene and consequently prevented atrophy. Despite the mechanisms still not being fully understood, NF-kB also seems to interfere with the IGF1-Akt signaling pathway. Indeed, it has been noted that conditional IKKbeta knockout mice are resistant to muscle atrophy but demonstrate Akt hyper-phosphorylation.', 'It promotes bone growth and muscle mass increase through the activation of specific signaling pathways. It has been found that IGF1 overexpression or chronic treatment can favor muscle hypertrophy and can induce recovery from muscle damage in animal models of neuromuscular diseases. Thus, exogenous IGF-1 may have therapeutic properties in the treatment of degenerative muscle diseases, sarcopenia, and other forms of skeletal muscle atrophy.', 'It has been found that IGF1 overexpression or chronic treatment can favor muscle hypertrophy and can induce recovery from muscle damage in animal models of neuromuscular diseases. Thus, exogenous IGF-1 may have therapeutic properties in the treatment of degenerative muscle diseases, sarcopenia, and other forms of skeletal muscle atrophy. IGF 1 appears to be able to improve the condition of muscle disuse through the regulation of protein synthesis or the control of post-transcriptional mechanisms.', 'Thus, exogenous IGF-1 may have therapeutic properties in the treatment of degenerative muscle diseases, sarcopenia, and other forms of skeletal muscle atrophy. IGF 1 appears to be able to improve the condition of muscle disuse through the regulation of protein synthesis or the control of post-transcriptional mechanisms. Among the different isoforms of IGF1, IGF-1Ea is the one capable of increasing strength and muscle mass.', 'IGF 1 appears to be able to improve the condition of muscle disuse through the regulation of protein synthesis or the control of post-transcriptional mechanisms. Among the different isoforms of IGF1, IGF-1Ea is the one capable of increasing strength and muscle mass. Insulin and IGF1 have been shown to activate the PI3K-AKT-mTOR pathways, fundamental in hypertrophy (Figure 4).', 'Paracrine effects of IGF-1 overexpression on the functional decline due to skeletal muscle disuse: Molecular and functional evaluation in hindlimb unloaded MLC/mIgf-1 transgenic mice', 'A Localized infusion of IGF-1 results in skeletal muscle hypertrophy in rats']\n",
            "There are 7 occurrences (each are AT MOST 3-setences long SO MAX of 21 sentences in total) of 16000:IGF1.\n",
            "\n",
            "Gene(17928)\n",
            "  Symbol          : Myog\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : myogenin\n",
            "  Also Known As   : MYF4, bHLHc3, myo\n",
            "  In-text Name    : myogenin\n",
            "  Occurrences     : [\"Activation of NF-kappaB increases the expression of the inducible nitric oxide synthase (iNOS) in muscle cells that sequester HuR (RNA-binding protein) by preventing transcription of MyoD. Denervation-induced atrophy is related to the upregulation of specific histone deacetylases (HDAC), able to repress a negative regulator of myogenin, with an increase in MuRF1 expression and muscle wasting. AMPK (protein kinase activated by 5'adenosine monophosphate) is also involved in muscle atrophy.\"]\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 17928:myogenin.\n",
            "\n",
            "Gene(11758)\n",
            "  Symbol          : Prdx6\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : peroxiredoxin 6\n",
            "  Also Known As   : 1-Cys Prx, 1-cysPrx, 9430088D19Rik, Aop2, Brp-12, CP-3, GPx, LPCAT-5, Ltw-4, Ltw4, Lvtw-4, NSGPx, ORF06, Prdx5, aiPLA2\n",
            "  In-text Name    : peroxiredoxin-6\n",
            "  Occurrences     : ['Fast and slow muscles have adapted to disuse differently. In HU Sol, superoxide dismutase (Zn/CuSOD) expression is increased, peroxiredoxin-6 (PRDX6) and carbonic anhydrase 3 (CAH III) expression is reduced, thus underlining a weakening of the antioxidant defense systems. Although an increase in Zn/Cu SOD seems protective against oxidative stress, the reduced synthesis of enzymes downstream of Zn/Cu SOD, such as peroxiredoxin (PRDX6), can be responsible for hydrogen peroxide accumulation and thus for the oxidative stress increase.', 'In HU Sol, superoxide dismutase (Zn/CuSOD) expression is increased, peroxiredoxin-6 (PRDX6) and carbonic anhydrase 3 (CAH III) expression is reduced, thus underlining a weakening of the antioxidant defense systems. Although an increase in Zn/Cu SOD seems protective against oxidative stress, the reduced synthesis of enzymes downstream of Zn/Cu SOD, such as peroxiredoxin (PRDX6), can be responsible for hydrogen peroxide accumulation and thus for the oxidative stress increase. Furthermore, the heat shock proteins (HSPs) that are able to protect cells from oxidative stress in this situation were found to be downregulated.', 'Furthermore, the heat shock proteins (HSPs) that are able to protect cells from oxidative stress in this situation were found to be downregulated. In addition, CAH III and PRDX6 are upregulated in Gas muscle during HU. Hence, no alteration of the antioxidant defense systems was observed in HU Gas.']\n",
            "There are 3 occurrences (each are AT MOST 3-setences long SO MAX of 9 sentences in total) of 11758:peroxiredoxin-6.\n",
            "\n",
            "Gene(140939)\n",
            "  Symbol          : Trim63\n",
            "  Organism        : Rattus norvegicus\n",
            "  Full Name       : tripartite motif containing 63\n",
            "  Also Known As   : Murf, Murf1, Rnf28\n",
            "  In-text Name    : MuRF1\n",
            "  Occurrences     : ['Nevertheless, this response might turn into an adverse event with boosted muscle catabolism. A decrease in muscle fiber cross-sectional area (CSA) and an increase in mRNA encoding for the ubiquitin protein ligases, atrogin, and MuRF1, were found during the earliest days of disuse. Together with muscle atrophy, we found a modification of the percentage of the various isoforms of the myosin heavy chain (MHC) in the soleus muscle.', 'In a preclinical model of cisplatin-induced cachexia, severe atrophy has been found in terms of cross-sectional area (CSA) decrease, and MURF-1 increased expression associated with a significant increase in resting intracellular calcium and functional modifications. Indeed, a decrease in membrane ionic conductances with an increase in sarcolemma excitability was found in EDL muscle.', 'In fact, it preserved resting gCl and resting cytosolic calcium concentration (restCa), corrected permeability of the calcium membrane through the sarcolemma cation channels, and improved the phenotypic transition induced by HU. In addition, taurine restored the expression of MURF-1, suggesting an early protective effect of this amino acid in the attenuation of the atrophic process. Some studies have shown that in C2C12 myotubes, taurine avoids muscle atrophy induced by cisplatin by restoring microtubular and mitochondrial function and reducing the overload and localization of autophagolysosomes.']\n",
            "There are 3 occurrences (each are AT MOST 3-setences long SO MAX of 9 sentences in total) of 140939:MuRF1.\n",
            "\n",
            "Gene(12723)\n",
            "  Symbol          : Clcn1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : chloride channel, voltage-sensitive 1\n",
            "  Also Known As   : Clc-1, Clc1, SMCC1, adr, mto, myotonia, nmf355\n",
            "  In-text Name    : ClC-1\n",
            "  Occurrences     : ['Accordingly, the expression and function of proteins involved in the control of muscle excitability, excitation-contraction coupling, energy metabolism, and contractile properties are changed toward those typical of the fast phenotype. Indeed, the activity and expression of the ClC-1 muscle chloride channel that sustains the resting chloride conductance (gCl) were increased in HU rodents toward the value recorded in the fast muscles, being higher with respect to the slow-ones for physiological reasons. As already shown, gCl is pivotal for sarcolemma stability and for the regulation of the electrical and contractile properties.', 'Very little is known about the mechanism that regulates the expression of ClC1. It would appear that the expression of the ClC1 channel is under nerve control.', 'Very little is known about the mechanism that regulates the expression of ClC1. It would appear that the expression of the ClC1 channel is under nerve control. There are two regulatory pathways proposed: the pathway involving MyoD, belonging to the family of helix-loop-helix transcription factors, and the NFAT signaling pathway involving calcium-dependent calcineurin.', 'Between the two, only the first way seems to be involved during the HU. This increase in gCl is closely related to an increase in the activity of ClC1 channels and consequently results in a slow-to-fast transition of the muscle fibers type. It is possible to prevent muscle impairment and motor disability after space flight by pharmacologically modifying the gCl in muscle fibers.', 'Our previous findings have demonstrated important modification of the activity of skeletal muscle protein during aging associated with increased ROS levels and a decrease in the protective process. A downregulation of the expression of ClC-1 protein, linked with an abnormal decrease in the resting chloride conductance (gCl), was observed in the fast-twitch EDL muscle. This channel is a key determinant of muscle excitability; indeed, a marked reduction in gCl is characteristic of disabling syndromes such as Myotonia Congenita.', 'Thus, this reduction can justify the development of skeletal muscle symptoms complained by elderly subjects, such as myalgia and muscle weakness. The activity of ClC-1 is regulated by protein kinase C (PKC), which activation is responsible for channel closure. This regulation is modified during aging and contributes to gCl reduction.', 'Protein kinase C theta (PKCtheta) modulates the ClC-1 chloride channel activity and skeletal muscle phenotype: A biophysical and gene expression study in mouse models lacking the PKCtheta', 'Aging-associated down-regulation of ClC-1 expression in skeletal muscle: Phenotypic-independent relation to the decrease of chloride conductance']\n",
            "There are 8 occurrences (each are AT MOST 3-setences long SO MAX of 24 sentences in total) of 12723:ClC-1.\n",
            "\n",
            "Gene(24681)\n",
            "  Symbol          : Prkcg\n",
            "  Organism        : Rattus norvegicus\n",
            "  Full Name       : protein kinase C, gamma\n",
            "  Also Known As   : PKC, PKCI, Prkc, Prkcc, RATPKCI\n",
            "  In-text Name    : PKC\n",
            "  Occurrences     : ['Thus, the HU Sol muscle loses its postural function and assumes characteristics of fast muscles. Our previous studies have shown that after 3 days of HU, the increase in gCl in Sol is also accountable for a reduction in PKC activity and/or activation of a phosphatase, keeping the ClC-1 channels in an active state. We found that the modification of gCl in the HU Sol muscle precedes the modification of the amount of MHC isoforms, proposing a role of this parameter in promoting the phenotype transition.', 'It would therefore be useful to assess the possible link between PKC expression and/or activity and insulin resistance in models of reduced motor activity, such as the HU rodent. Thus, a possible therapeutical approach able to modulate the activity of PKC can be suitable to reduce the damage induced by muscle disuse.', 'Numerous studies indicate that insulin can modulate the expression of PKC. It would therefore be useful to assess the possible link between PKC expression and/or activity and insulin resistance in models of reduced motor activity, such as the HU rodent. Thus, a possible therapeutical approach able to modulate the activity of PKC can be suitable to reduce the damage induced by muscle disuse.', 'Taurine is a sulfonic amino acid prevalent in excitable tissues and of fundamental importance in the function of skeletal muscle. Taurine controls muscle excitability directly or mediated by PKC and modulates intracellular calcium homeostasis. Some studies have shown that muscle disuse induces a reduction in the taurine content in postural muscles.']\n",
            "There are 4 occurrences (each are AT MOST 3-setences long SO MAX of 12 sentences in total) of 24681:PKC.\n",
            "\n",
            "Gene(111671)\n",
            "  Symbol          : Myhc\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : myosin heavy chain, cardiac muscle complex\n",
            "  Also Known As   : MyHC\n",
            "  In-text Name    : MyHC\n",
            "  Occurrences     : ['Accordingly, Sharlo et al. (2019) did not find significant changes in MyHC type I or fast MyHC fibers at 3-days of unloading. In addition, the PGC-1alpha transcript and protein were unchanged during the same period.', 'Rapid decline in MyHC I(beta) mRNA expression in rat soleus during hindlimb unloading is associated with AMPK dephosphorylation']\n",
            "There are 2 occurrences (each are AT MOST 3-setences long SO MAX of 6 sentences in total) of 111671:MyHC.\n",
            "\n",
            "Gene(23885)\n",
            "  Symbol          : Gmcl1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : germ cell-less, spermatogenesis associated 1\n",
            "  Also Known As   : 2810049L19Rik, Btbd13, DIP, Gcl, Gcl-1, glc-1, mglc-1\n",
            "  In-text Name    : gCl\n",
            "  Occurrences     : ['Our previous studies have shown that after 3 days of HU, the increase in gCl in Sol is also accountable for a reduction in PKC activity and/or activation of a phosphatase, keeping the ClC-1 channels in an active state. We found that the modification of gCl in the HU Sol muscle precedes the modification of the amount of MHC isoforms, proposing a role of this parameter in promoting the phenotype transition. Accordingly, Sharlo et al.', 'Indeed, the activity and expression of the ClC-1 muscle chloride channel that sustains the resting chloride conductance (gCl) were increased in HU rodents toward the value recorded in the fast muscles, being higher with respect to the slow-ones for physiological reasons. As already shown, gCl is pivotal for sarcolemma stability and for the regulation of the electrical and contractile properties. Thus, the HU Sol muscle loses its postural function and assumes characteristics of fast muscles.', 'This increase in gCl is closely related to an increase in the activity of ClC1 channels and consequently results in a slow-to-fast transition of the muscle fibers type. It is possible to prevent muscle impairment and motor disability after space flight by pharmacologically modifying the gCl in muscle fibers.', 'A downregulation of the expression of ClC-1 protein, linked with an abnormal decrease in the resting chloride conductance (gCl), was observed in the fast-twitch EDL muscle. This channel is a key determinant of muscle excitability; indeed, a marked reduction in gCl is characteristic of disabling syndromes such as Myotonia Congenita. Thus, this reduction can justify the development of skeletal muscle symptoms complained by elderly subjects, such as myalgia and muscle weakness.', 'The activity of ClC-1 is regulated by protein kinase C (PKC), which activation is responsible for channel closure. This regulation is modified during aging and contributes to gCl reduction. ', 'However, despite its action at the protein level, Sol muscle function was not restored after ND treatment. In addition, ND was not able to modify gCl and restCa or reverse the slow-to-fast phenotypic transition. Myostatin, a protein discovered during studies on cell differentiation and proliferation, inhibits muscle development.', 'The oral administration of taurine in HU rats modulated some muscle parameters involved in excitability and excitation-contraction coupling. In fact, it preserved resting gCl and resting cytosolic calcium concentration (restCa), corrected permeability of the calcium membrane through the sarcolemma cation channels, and improved the phenotypic transition induced by HU. In addition, taurine restored the expression of MURF-1, suggesting an early protective effect of this amino acid in the attenuation of the atrophic process.']\n",
            "There are 7 occurrences (each are AT MOST 3-setences long SO MAX of 21 sentences in total) of 23885:gCl.\n",
            "\n",
            "Gene(3630)\n",
            "  Symbol          : INS\n",
            "  Organism        : Homo sapiens\n",
            "  Full Name       : insulin\n",
            "  Also Known As   : IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10, PNDM4\n",
            "  In-text Name    : insulin\n",
            "  Occurrences     : ['Numerous studies indicate that insulin can modulate the expression of PKC. It would therefore be useful to assess the possible link between PKC expression and/or activity and insulin resistance in models of reduced motor activity, such as the HU rodent.', 'Among the different isoforms of IGF1, IGF-1Ea is the one capable of increasing strength and muscle mass. Insulin and IGF1 have been shown to activate the PI3K-AKT-mTOR pathways, fundamental in hypertrophy (Figure 4). Insulin/IGF1 signaling interferes with the mTOR kinase, which, in turn, cooperates with different proteins to form two different complexes: the rapamycin-sensitive TORC1 complex, which includes Raptor, and the rapamycin-insensitive TORC2 complex, which includes Rictor.', 'Insulin and IGF1 have been shown to activate the PI3K-AKT-mTOR pathways, fundamental in hypertrophy (Figure 4). Insulin/IGF1 signaling interferes with the mTOR kinase, which, in turn, cooperates with different proteins to form two different complexes: the rapamycin-sensitive TORC1 complex, which includes Raptor, and the rapamycin-insensitive TORC2 complex, which includes Rictor. While the Rictor knockout mice in the muscle do not exhibit an evident phenotype, Raptor and mTOR-deficient mice show decreased growth of fast but not of slow muscle fibers.', 'Association between Sarcopenia and Insulin-Like Growth Factor-1, Myostatin, and Insulin Resistance in Elderly Patients Undergoing Hemodialysis', 'Specific protein kinase C isoforms as transducers and modulators of insulin signaling', 'Enhanced dystrophic progression in mdx mice by exercise and beneficial effects of taurine and insulin-like growth factor-1', 'Insulin and IGF1 activate the PI3K-AKT-mTOR pathway, resulting in protein synthesis and hypertrophy. On the other hand, disuse condition leads to a blockage of the AKT signaling pathway.']\n",
            "There are 7 occurrences (each are AT MOST 3-setences long SO MAX of 21 sentences in total) of 3630:insulin.\n",
            "\n",
            "Gene(11829)\n",
            "  Symbol          : Aqp4\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : aquaporin 4\n",
            "  Also Known As   : WCH4\n",
            "  In-text Name    : aquaporin-4\n",
            "  Occurrences     : ['Moreover, the immunoblotting technique shows the involvement of other channels. An increase in aquaporin-4 (AQP4) water channel in Sol muscle was found during simulated microgravity in response to muscle atrophy. This effect parallels the HU-induced slow-to-fast twitch conversion.', 'Muscle loading modulates aquaporin-4 expression in skeletal muscle']\n",
            "There are 2 occurrences (each are AT MOST 3-setences long SO MAX of 6 sentences in total) of 11829:aquaporin-4.\n",
            "\n",
            "Gene(83535)\n",
            "  Symbol          : Kcnj11\n",
            "  Organism        : Rattus norvegicus\n",
            "  Full Name       : potassium inwardly-rectifying channel, subfamily J, member 11\n",
            "  Also Known As   : Kir6.2\n",
            "  In-text Name    : Kir6.2\n",
            "  Occurrences     : ['Non-atrophic fibers MHC-IIa had higher K(ATP) currents with respect to the atrophic fibers. Fast-twitch muscles were not affected by atrophy in 14-day HU rats, and this is associated with the higher expression and activity of Kir6.2/SUR1 subunits of the K(ATP) channels, which characterize the fast muscle phenotype. The in vitro application of glibenclamide, a K(ATP) channel blocker, reduced the K(ATP) currents, and this effect is associated with atrophy.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 83535:Kir6.2.\n",
            "\n",
            "Gene(9780)\n",
            "  Symbol          : PIEZO1\n",
            "  Organism        : Homo sapiens\n",
            "  Full Name       : piezo type mechanosensitive ion channel component 1 (Er blood group)\n",
            "  Also Known As   : DHS, ER, FAM38A, LMPH3, LMPHM6, Mib\n",
            "  In-text Name    : Piezo 1\n",
            "  Occurrences     : ['Recent studies have highlighted that the Ca2+-associated-Piezo 1 channel is involved in muscle atrophy. Piezo 1 is in charge of maintaining constant calcium levels in skeletal muscle; thus, inhibition of Piezo 1 causes muscle atrophy through a signaling pathway involving the transcription factor Kruppel-like factor 15 (KLF15) and the cytokine interleukin-6 (IL-6). In addition, a reduced expression of Piezo 1 was observed in skeletal muscle biopsies of patients undergoing cast fixation after bone fracture and then immobilization with respect to control subjects.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 9780:Piezo 1.\n",
            "\n",
            "Gene(234839)\n",
            "  Symbol          : Piezo1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : piezo-type mechanosensitive ion channel component 1\n",
            "  Also Known As   : 9630020g22, Fam38a, mKIAA0233\n",
            "  In-text Name    : Piezo 1\n",
            "  Occurrences     : ['Piezo 1 is in charge of maintaining constant calcium levels in skeletal muscle; thus, inhibition of Piezo 1 causes muscle atrophy through a signaling pathway involving the transcription factor Kruppel-like factor 15 (KLF15) and the cytokine interleukin-6 (IL-6). In addition, a reduced expression of Piezo 1 was observed in skeletal muscle biopsies of patients undergoing cast fixation after bone fracture and then immobilization with respect to control subjects. In addition, it was shown that in mice in which the hind limbs were immobilized for three days, an increase in KLF15 was seen.', 'Finally, chromatin immunoprecipitation analysis showed how KLF15 binds to the promoter region of the Il6 gene. The relationship between Piezo 1, KLF15, and IL6 was clearly assessed by treating primary mouse myofibers or C2C12 myotubes with GsMTx-4, a pharmacological inhibitor of Piezo1; this compound was able to increase KLF15 and IL6 levels. Interestingly, KLF15 mRNA was increased by glucocorticoids, thus triggering muscle atrophy.']\n",
            "There are 2 occurrences (each are AT MOST 3-setences long SO MAX of 6 sentences in total) of 234839:Piezo 1.\n",
            "\n",
            "Gene(66277)\n",
            "  Symbol          : Klf15\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : Kruppel-like transcription factor 15\n",
            "  Also Known As   : 1810013I09Rik, CKLF, KKLF, hlb444\n",
            "  In-text Name    : KLF15\n",
            "  Occurrences     : ['In addition, a reduced expression of Piezo 1 was observed in skeletal muscle biopsies of patients undergoing cast fixation after bone fracture and then immobilization with respect to control subjects. In addition, it was shown that in mice in which the hind limbs were immobilized for three days, an increase in KLF15 was seen. In contrast, in mice lacking KLF15 (M-KLF15KO mice), atrophy of skeletal muscle caused by immobilization was prevented.', 'In addition, it was shown that in mice in which the hind limbs were immobilized for three days, an increase in KLF15 was seen. In contrast, in mice lacking KLF15 (M-KLF15KO mice), atrophy of skeletal muscle caused by immobilization was prevented. In addition, in these M-KLF15KO mice, it was found that IL6 expression was also prevented.', 'In addition, in these M-KLF15KO mice, it was found that IL6 expression was also prevented. Finally, chromatin immunoprecipitation analysis showed how KLF15 binds to the promoter region of the Il6 gene. The relationship between Piezo 1, KLF15, and IL6 was clearly assessed by treating primary mouse myofibers or C2C12 myotubes with GsMTx-4, a pharmacological inhibitor of Piezo1; this compound was able to increase KLF15 and IL6 levels.', 'The relationship between Piezo 1, KLF15, and IL6 was clearly assessed by treating primary mouse myofibers or C2C12 myotubes with GsMTx-4, a pharmacological inhibitor of Piezo1; this compound was able to increase KLF15 and IL6 levels. Interestingly, KLF15 mRNA was increased by glucocorticoids, thus triggering muscle atrophy.']\n",
            "There are 4 occurrences (each are AT MOST 3-setences long SO MAX of 12 sentences in total) of 66277:KLF15.\n",
            "\n",
            "Gene(16193)\n",
            "  Symbol          : Il6\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : interleukin 6\n",
            "  Also Known As   : Il-6\n",
            "  In-text Name    : IL6\n",
            "  Occurrences     : ['In contrast, in mice lacking KLF15 (M-KLF15KO mice), atrophy of skeletal muscle caused by immobilization was prevented. In addition, in these M-KLF15KO mice, it was found that IL6 expression was also prevented. Finally, chromatin immunoprecipitation analysis showed how KLF15 binds to the promoter region of the Il6 gene.', 'Chronic Ouabain Prevents Na,K-ATPase Dysfunction and Targets AMPK and IL-6 in Disused Rat Soleus Muscle']\n",
            "There are 2 occurrences (each are AT MOST 3-setences long SO MAX of 6 sentences in total) of 16193:IL6.\n",
            "\n",
            "Gene(14815)\n",
            "  Symbol          : Nr3c1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : nuclear receptor subfamily 3, group C, member 1\n",
            "  Also Known As   : GR, Grl-1, Grl1\n",
            "  In-text Name    : glucocorticoid receptor\n",
            "  Occurrences     : ['It is thought that the inhibitory action of glucocorticoids on muscle protein synthesis derives mostly from the inhibition of the mTOR pathway. The glucocorticoid receptor promotes the expression of two genes, codifying for REDD1 and KLF15. REDD1 inhibits the activity of mTOR.', 'Role of skeletal muscle glucocorticoid receptor in systemic energy homeostasis', 'Crosstalk between glucocorticoid receptor and nutritional sensor mTOR in skeletal muscle']\n",
            "There are 3 occurrences (each are AT MOST 3-setences long SO MAX of 9 sentences in total) of 14815:glucocorticoid receptor.\n",
            "\n",
            "Gene(74747)\n",
            "  Symbol          : Ddit4\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : DNA-damage-inducible transcript 4\n",
            "  Also Known As   : 5830413E08Rik, REDD1, Rtp801, dig2\n",
            "  In-text Name    : REDD1\n",
            "  Occurrences     : ['The glucocorticoid receptor promotes the expression of two genes, codifying for REDD1 and KLF15. REDD1 inhibits the activity of mTOR. Inhibition of mTOR activates KLF15, promoting atrophy.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 74747:REDD1.\n",
            "\n",
            "Gene(12036)\n",
            "  Symbol          : Bcat2\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : branched chain aminotransferase 2, mitochondrial\n",
            "  Also Known As   : Bcat(m), Bcat-2, Eca40\n",
            "  In-text Name    : branched-chain aminotransferase 2\n",
            "  Occurrences     : ['Inhibition of mTOR activates KLF15, promoting atrophy. KLEF15 is a transcription factor involved in several metabolic processes in skeletal muscle, for example, in the upregulation of branched-chain aminotransferase 2 (BCAT2), which, in turn, induces the degradation of branched-chain amino acids. Furthermore, KLF15 contributes to muscle catabolism through the transcriptional regulation of FoxO1, atrogin-1, and MuRF1 (Figure 3).']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 12036:branched-chain aminotransferase 2.\n",
            "\n",
            "Gene(28999)\n",
            "  Symbol          : KLF15\n",
            "  Organism        : Homo sapiens\n",
            "  Full Name       : KLF transcription factor 15\n",
            "  Also Known As   : KKLF\n",
            "  In-text Name    : KLF15\n",
            "  Occurrences     : ['KLEF15 is a transcription factor involved in several metabolic processes in skeletal muscle, for example, in the upregulation of branched-chain aminotransferase 2 (BCAT2), which, in turn, induces the degradation of branched-chain amino acids. Furthermore, KLF15 contributes to muscle catabolism through the transcriptional regulation of FoxO1, atrogin-1, and MuRF1 (Figure 3). ', 'A Piezo1/KLF15/IL-6 axis mediates immobilization-induced muscle atrophy']\n",
            "There are 2 occurrences (each are AT MOST 3-setences long SO MAX of 6 sentences in total) of 28999:KLF15.\n",
            "\n",
            "Gene(14599)\n",
            "  Symbol          : Gh\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : growth hormone\n",
            "  Also Known As   : Gh1, Ghb1\n",
            "  In-text Name    : growth hormone\n",
            "  Occurrences     : ['Apart from the inhibitors, anabolic therapies to mitigate disuse atrophy are expected to be more effective than therapies aimed to contrast protein degradation. Several agents, such as anabolic or androgenic steroids, selective androgenic receptor modulators, growth hormone and analogs, myostatin inhibitors, beta-receptor agonists, and nutritional food, are suggested and have been shown to induce variable efficacy. ', 'Partial recovery of skeletal muscle sodium channel properties in aged rats chronically treated with growth hormone or the GH-secretagogue hexarelin', 'Growth hormone secretagogues prevent dysregulation of skeletal muscle calcium homeostasis in a rat model of cisplatin-induced cachexia']\n",
            "There are 3 occurrences (each are AT MOST 3-setences long SO MAX of 9 sentences in total) of 14599:growth hormone.\n",
            "\n",
            "Gene(3479)\n",
            "  Symbol          : IGF1\n",
            "  Organism        : Homo sapiens\n",
            "  Full Name       : insulin like growth factor 1\n",
            "  Also Known As   : IGF, IGF-I, IGFI, MGF\n",
            "  In-text Name    : IGF1\n",
            "  Occurrences     : ['8.1. IGF1 and Its Analogs as Anabolic Compounds to Improve Muscle Damage', 'Some studies conducted on animals and humans have highlighted the pivotal role of the IGF1 hormone in muscle disuse and other atrophic conditions. IGF1 is a hormone produced mainly by the liver and skeletal muscle.', 'Some studies conducted on animals and humans have highlighted the pivotal role of the IGF1 hormone in muscle disuse and other atrophic conditions. IGF1 is a hormone produced mainly by the liver and skeletal muscle. It promotes bone growth and muscle mass increase through the activation of specific signaling pathways.', 'While the Rictor knockout mice in the muscle do not exhibit an evident phenotype, Raptor and mTOR-deficient mice show decreased growth of fast but not of slow muscle fibers. In addition, overexpression of IGF-1 has been shown to have limited effects in preventing HU-induced muscle atrophy since, after HU, slow or fast muscles are no longer responsive to the hypertrophic action of IGF-1. However, it has been observed that the increase in gCl during HU in Sol muscle is counteracted by overexpression of IGF1, thus playing an important role in the phenotype transition (Figure 4).', 'In addition, overexpression of IGF-1 has been shown to have limited effects in preventing HU-induced muscle atrophy since, after HU, slow or fast muscles are no longer responsive to the hypertrophic action of IGF-1. However, it has been observed that the increase in gCl during HU in Sol muscle is counteracted by overexpression of IGF1, thus playing an important role in the phenotype transition (Figure 4).']\n",
            "There are 5 occurrences (each are AT MOST 3-setences long SO MAX of 15 sentences in total) of 3479:IGF1.\n",
            "\n",
            "Gene(78757)\n",
            "  Symbol          : Rictor\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : RPTOR independent companion of MTOR, complex 2\n",
            "  Also Known As   : 4921505C17Rik, 6030405M08Rik, AVO3, D530039E11Rik\n",
            "  In-text Name    : Rictor\n",
            "  Occurrences     : ['Insulin/IGF1 signaling interferes with the mTOR kinase, which, in turn, cooperates with different proteins to form two different complexes: the rapamycin-sensitive TORC1 complex, which includes Raptor, and the rapamycin-insensitive TORC2 complex, which includes Rictor. While the Rictor knockout mice in the muscle do not exhibit an evident phenotype, Raptor and mTOR-deficient mice show decreased growth of fast but not of slow muscle fibers. In addition, overexpression of IGF-1 has been shown to have limited effects in preventing HU-induced muscle atrophy since, after HU, slow or fast muscles are no longer responsive to the hypertrophic action of IGF-1.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 78757:Rictor.\n",
            "\n",
            "Gene(11835)\n",
            "  Symbol          : Ar\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : androgen receptor\n",
            "  Also Known As   : Tfm\n",
            "  In-text Name    : androgen receptor\n",
            "  Occurrences     : ['In the HU rats, ND is able to counteract HU-induced Sol muscle weight loss. This anabolic effect is mediated by its binding to the androgen receptor (AR), which leads to the activation of specific DNA sequences and affects the transcriptional activity of specific anabolic genes. The anabolic effect can induce an increase in protein synthesis with a hypertrophic effect.', 'In this regard, it is important to underline that different clinical trials have been recruited to evaluate the efficacy of several pharmacological approaches in the different atrophy conditions For muscle atrophy due to disuse, the effects of leucine supplementation and anti-myostatin drugs have been studied. For sarcopenia, clinical trials reported different compounds, such as creatine, testosterone, bimagrumab, BCAA, androgen receptor modulators (SARM), losartan, citrulline, and IGF1 have been tested. In addition, different compounds have been tested for cancer cachexia atrophy, among which: androgen receptor modulators, bimagrumab, ghrelin, and growth hormone secretagogue receptor synthetic agonists.', 'For sarcopenia, clinical trials reported different compounds, such as creatine, testosterone, bimagrumab, BCAA, androgen receptor modulators (SARM), losartan, citrulline, and IGF1 have been tested. In addition, different compounds have been tested for cancer cachexia atrophy, among which: androgen receptor modulators, bimagrumab, ghrelin, and growth hormone secretagogue receptor synthetic agonists.', 'GLPG0492, a novel selective androgen receptor modulator, improves muscle performance in the exercised-mdx mouse model of muscular dystrophy']\n",
            "There are 4 occurrences (each are AT MOST 3-setences long SO MAX of 12 sentences in total) of 11835:androgen receptor.\n",
            "\n",
            "Gene(67204)\n",
            "  Symbol          : Eif2s2\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : eukaryotic translation initiation factor 2 subunit 2 beta\n",
            "  Also Known As   : 2810026E11Rik, 38kDa, D2Ertd303e, EIF2, EIF2B\n",
            "  In-text Name    : eIF2\n",
            "  Occurrences     : ['In this condition, ND had a beneficial effect on protein synthesis. The eIF2 protein (eukaryotic initiation factor of protein translation) was decreased during HU and restored in HU-ND mice. The ND treatment prevented the alteration in MyoD and Notch-1 expression suggesting the advancement of myogenic stem cell differentiation in response to atrophy.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 67204:eIF2.\n",
            "\n",
            "Gene(2660)\n",
            "  Symbol          : MSTN\n",
            "  Organism        : Homo sapiens\n",
            "  Full Name       : myostatin\n",
            "  Also Known As   : GDF8, MSLHP\n",
            "  In-text Name    : Myostatin\n",
            "  Occurrences     : ['In addition, ND was not able to modify gCl and restCa or reverse the slow-to-fast phenotypic transition. Myostatin, a protein discovered during studies on cell differentiation and proliferation, inhibits muscle development. It is produced by skeletal muscle cells, and its activity is regulated by the presence of an inhibitor called follistatin.', 'It is produced by skeletal muscle cells, and its activity is regulated by the presence of an inhibitor called follistatin. Myostatin has aroused particular interest among scientists in the study of myostatin inhibitors. However, myostatin inhibitors have shown important side effects in humans.', 'Myostatin has aroused particular interest among scientists in the study of myostatin inhibitors. However, myostatin inhibitors have shown important side effects in humans. Interestingly, beta-2-adrenergic agonists, including clenbuterol or formoterol, have been identified as possible anti-atrophic drugs.', 'Different drugs and natural compounds have been described. In this regard, it is important to underline that different clinical trials have been recruited to evaluate the efficacy of several pharmacological approaches in the different atrophy conditions For muscle atrophy due to disuse, the effects of leucine supplementation and anti-myostatin drugs have been studied. For sarcopenia, clinical trials reported different compounds, such as creatine, testosterone, bimagrumab, BCAA, androgen receptor modulators (SARM), losartan, citrulline, and IGF1 have been tested.']\n",
            "There are 4 occurrences (each are AT MOST 3-setences long SO MAX of 12 sentences in total) of 2660:Myostatin.\n",
            "\n",
            "Gene(14313)\n",
            "  Symbol          : Fst\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : follistatin\n",
            "  Also Known As   : FS\n",
            "  In-text Name    : follistatin\n",
            "  Occurrences     : ['Myostatin, a protein discovered during studies on cell differentiation and proliferation, inhibits muscle development. It is produced by skeletal muscle cells, and its activity is regulated by the presence of an inhibitor called follistatin. Myostatin has aroused particular interest among scientists in the study of myostatin inhibitors.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 14313:follistatin.\n",
            "\n",
            "Gene(11651)\n",
            "  Symbol          : Akt1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : thymoma viral proto-oncogene 1\n",
            "  Also Known As   : Akt, LTR-akt, PKB, PKB/Akt, PKBalpha, Rac\n",
            "  In-text Name    : Akt\n",
            "  Occurrences     : ['These drugs promote protein synthesis and inhibit its degradation. Most of the effects of clenbuterol are mediated by the Akt-mTOR signaling pathway. However, according to some studies, the action of beta2-adrenergic agonists is expressed through the inhibition of glycogen synthase kinase-3 beta (GSK-3beta) and the activation of another kinase, such as the p70S6K1.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 11651:Akt.\n",
            "\n",
            "Gene(56637)\n",
            "  Symbol          : Gsk3b\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : glycogen synthase kinase 3 beta\n",
            "  Also Known As   : 7330414F15Rik, 8430431H08Rik, GSK-3, GSK-3beta, GSK3\n",
            "  In-text Name    : glycogen synthase kinase-3 beta\n",
            "  Occurrences     : ['Most of the effects of clenbuterol are mediated by the Akt-mTOR signaling pathway. However, according to some studies, the action of beta2-adrenergic agonists is expressed through the inhibition of glycogen synthase kinase-3 beta (GSK-3beta) and the activation of another kinase, such as the p70S6K1. Although they are very effective, these drugs are modestly used due to the possible side effects that could occur in the cardiac tissue.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 56637:glycogen synthase kinase-3 beta.\n",
            "\n",
            "Gene(58991)\n",
            "  Symbol          : Ghrl\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : ghrelin\n",
            "  Also Known As   : 2210006E23Rik, Ghr, MTLRP, MTLRPAP, m46\n",
            "  In-text Name    : ghrelin\n",
            "  Occurrences     : ['Another interesting compound is ghrelin, a stomach-releasing peptide that stimulates the appetite and growth hormone secretion. It appears to play an important role in the treatment of sarcopenia and other atrophy conditions.', 'It appears to play an important role in the treatment of sarcopenia and other atrophy conditions. In fact, in one study, 20-month-old male WT and Ghrl -/- mice were used and fasted for 48 h. After 48 h, the muscle mass of the tibialis muscle was similar in the WT and Ghrl mice, while the mass of the gastrocnemius muscle was significantly reduced in the Ghrl -/- mice compared to the WT mice.', 'In fact, in one study, 20-month-old male WT and Ghrl -/- mice were used and fasted for 48 h. After 48 h, the muscle mass of the tibialis muscle was similar in the WT and Ghrl mice, while the mass of the gastrocnemius muscle was significantly reduced in the Ghrl -/- mice compared to the WT mice. Ghrelin null mice (Ghrl -/-) are more prone to fasting-induced muscle atrophy, particularly in the Gas muscle.', 'After 48 h, the muscle mass of the tibialis muscle was similar in the WT and Ghrl mice, while the mass of the gastrocnemius muscle was significantly reduced in the Ghrl -/- mice compared to the WT mice. Ghrelin null mice (Ghrl -/-) are more prone to fasting-induced muscle atrophy, particularly in the Gas muscle. In these mice, there is also a reduced expression of the myogenic regulator MyoD and a higher expression of the protein degradation marker MuRF1.', 'Protective Effects of Ghrelin on Fasting-Induced Muscle Atrophy in Aging Mice']\n",
            "There are 5 occurrences (each are AT MOST 3-setences long SO MAX of 15 sentences in total) of 58991:ghrelin.\n",
            "\n",
            "Gene(13609)\n",
            "  Symbol          : S1pr1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : sphingosine-1-phosphate receptor 1\n",
            "  Also Known As   : Edg1, Lpb1, S1p, S1p1\n",
            "  In-text Name    : S1P\n",
            "  Occurrences     : ['It is also interesting the role of S1P (sphingosine 1 phosphate), a signaling sphingolipid, defined as a bioactive lipid mediator. S1P is involved in both physiological and pathological processes. Furthermore, it has an important role in the activation and proliferation of satellite cells.', 'Indeed, S1P plays an important role in skeletal muscle regeneration in injured mdx mice. In S1P null mice, the contraction tension of the EDL muscle was smaller with respect to that of the WT.', 'Furthermore, it has an important role in the activation and proliferation of satellite cells. Indeed, S1P plays an important role in skeletal muscle regeneration in injured mdx mice. In S1P null mice, the contraction tension of the EDL muscle was smaller with respect to that of the WT.', 'It is also interesting the role of S1P (sphingosine 1 phosphate), a signaling sphingolipid, defined as a bioactive lipid mediator. S1P is involved in both physiological and pathological processes.', 'Sphingosine 1-phosphate stimulates proliferation and migration of satellite cells: Role of S1P receptors']\n",
            "There are 5 occurrences (each are AT MOST 3-setences long SO MAX of 15 sentences in total) of 13609:S1P.\n",
            "\n",
            "Gene(21803)\n",
            "  Symbol          : Tgfb1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : transforming growth factor, beta 1\n",
            "  Also Known As   : TGF-beta1, TGFbeta1, Tgfb, Tgfb-1\n",
            "  In-text Name    : TGF-beta\n",
            "  Occurrences     : ['Recent studies have reported that losartan, an angiotensin 1 receptor antagonist, was able to partially protect soleus muscle from hindlimb unloading-induced atrophy, likely through a decreased TGF-beta signaling and inhibition of remodeling.', 'Pharmaceutical Compounds That Could Prevent or Restore Muscle Atrophy   Effect Drug Mechanism of Action   Inhibition of catabolic pathways CalpastatinPD150606L-arginine Calpain inhibitor Calpain inhibitornNOS activation and calpain inhibition   Inhibition of catabolic pathways Follistatin Myostatin inhibitor    Inhibition of catabolic pathways Bortezomib Proteasome inhibitor    Upregulation of anabolic pathway Losartan TGF-beta signaling inhibitor   Upregulation of Anabolic pathway beta2-adrenoreceptor agonists Akt-mTOR signaling pathway amelioration    Upregulation of Anabolic pathway Bimagrumab Monoclonal antibody against activin II receptor   Upregulation of Anabolic pathway Nandrolone Protein synthesis   Upregulation of Anabolic pathway Ghrelin Growth hormone secretion stimulation    Upregulation of Anabolic pathway  Insulin-like growth factor (IGF)-1 and analogs Myoblast proliferation   ', 'Losartan treatment attenuates hindlimb unloading-induced atrophy in the soleus muscle of female rats via canonical TGF-beta signaling']\n",
            "There are 3 occurrences (each are AT MOST 3-setences long SO MAX of 9 sentences in total) of 21803:TGF-beta.\n",
            "\n",
            "Gene(17700)\n",
            "  Symbol          : Mstn\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : myostatin\n",
            "  Also Known As   : Cmpt, Gdf8\n",
            "  In-text Name    : myostatin\n",
            "  Occurrences     : ['For instance, ursolic acid stimulates muscle hypertrophy and reduces the expression of MuRF-1 in soleus and extensor digitorum longus (EDL) muscle of chronic kidney disease mice. It also reduced myostatin and insulin-like growth factor-binding protein 3 (IGFBP3) in dexamethasone-treated C2C12 cell lines. Apigenin was found to increase protein expression and skeletal muscle mass.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 17700:myostatin.\n",
            "\n",
            "Gene(171043)\n",
            "  Symbol          : Fbxo32\n",
            "  Organism        : Rattus norvegicus\n",
            "  Full Name       : F-box protein 32\n",
            "  Also Known As   : Atrogin1, MAFbx\n",
            "  In-text Name    : MAFbx\n",
            "  Occurrences     : ['D-methionine, another essential amino acid found in some aliments such as yogurt, cheese, meat, and eggs, increases soleus and gastrocnemius muscle weight in the cisplatin-induced rat muscle atrophy model. The action of D-methionine is due to the downregulation of MAFbx and MuRF1 and to the upregulation of myogenin and MyoD.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 171043:MAFbx.\n",
            "\n",
            "Gene(15568)\n",
            "  Symbol          : Elavl1\n",
            "  Organism        : Mus musculus\n",
            "  Full Name       : ELAV like RNA binding protein 1\n",
            "  Also Known As   : 2410055N02Rik, HUR, Hua\n",
            "  In-text Name    : HuR\n",
            "  Occurrences     : ['NF-kappa B-mediated MyoD decay during muscle wasting requires nitric oxide synthase mRNA stabilization, HuR protein, and nitric oxide release']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 15568:HuR.\n",
            "\n",
            "Gene(29148)\n",
            "  Symbol          : Myog\n",
            "  Organism        : Rattus norvegicus\n",
            "  Full Name       : myogenin\n",
            "  Also Known As   : Myogenin\n",
            "  In-text Name    : Myogenin\n",
            "  Occurrences     : ['Myogenin and class II HDACs control neurogenic muscle atrophy by inducing E3 ubiquitin ligases']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 29148:Myogenin.\n",
            "\n",
            "Gene(207)\n",
            "  Symbol          : AKT1\n",
            "  Organism        : Homo sapiens\n",
            "  Full Name       : AKT serine/threonine kinase 1\n",
            "  Also Known As   : AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA\n",
            "  In-text Name    : AKT\n",
            "  Occurrences     : ['Insulin and IGF1 activate the PI3K-AKT-mTOR pathway, resulting in protein synthesis and hypertrophy. On the other hand, disuse condition leads to a blockage of the AKT signaling pathway. The arrows indicates an increase of protein synthesis in normal condition or a reduction of protein synthesis during disuse.']\n",
            "There are 1 occurrences (each are AT MOST 3-setences long SO MAX of 3 sentences in total) of 207:AKT.\n",
            "\n"
          ]
        }
      ],
      "source": [
        "!pip install biopython\n",
        "import xml.etree.ElementTree as ET\n",
        "from Bio import Entrez\n",
        "import re\n",
        "import time\n",
        "\n",
        "class Gene:\n",
        "    def __init__(self, gene_id):\n",
        "        self.gene_id = gene_id\n",
        "        self.occurrences = []  # list to store snippet(s) where the gene was mentioned\n",
        "        self.symbol = None\n",
        "        self.organism = None\n",
        "        self.full_name = None\n",
        "        self.also_known_as = None\n",
        "        self.name_from_article = None\n",
        "\n",
        "    def add_occurrence(self, snippet):\n",
        "        if snippet not in self.occurrences:  # Avoid duplicates\n",
        "            self.occurrences.append(snippet)\n",
        "\n",
        "    def set_name_from_article(self, name_from_article):\n",
        "        \"\"\"Sets the temporary name of the gene. This is the name accroding to the article\"\"\"\n",
        "        # will be used if the official name is not available\n",
        "        self.name_from_article = name_from_article\n",
        "\n",
        "    def get_name_from_article(self):\n",
        "        return self.name_from_article\n",
        "\n",
        "    def get_occurrences(self):\n",
        "        return self.occurrences\n",
        "\n",
        "    def get_also_known_as(self):\n",
        "        return self.also_known_as\n",
        "\n",
        "    def get_gene_id(self):\n",
        "        return self.gene_id\n",
        "\n",
        "    def update_info(self, symbol, organism, full_name, also_known_as):\n",
        "        self.symbol = symbol\n",
        "        self.organism = organism\n",
        "        self.full_name = full_name\n",
        "        self.also_known_as = also_known_as\n",
        "\n",
        "    def __repr__(self):\n",
        "        return (f\"Gene({self.gene_id})\\n\"\n",
        "                f\"  Symbol          : {self.symbol}\\n\"\n",
        "                f\"  Organism        : {self.organism}\\n\"\n",
        "                f\"  Full Name       : {self.full_name}\\n\"\n",
        "                f\"  Also Known As   : {self.also_known_as}\\n\"\n",
        "                f\"  In-text Name    : {self.name_from_article}\\n\"\n",
        "                f\"  Occurrences     : {self.occurrences}\")   # occurrences is a list of 3-sentence snippets\n",
        "\n",
        "def parse_xml_file(xml_path):\n",
        "    \"\"\"Parses the XML file and returns a gene dictionary keyed by gene ID.\"\"\"\n",
        "    tree = ET.parse(xml_path)\n",
        "    root = tree.getroot()\n",
        "    gene_dict = {}\n",
        "\n",
        "    for document in root.findall('document'):\n",
        "        for passage in document.findall('passage'):\n",
        "            section_type_elem = passage.find(\"infon[@key='section_type']\")\n",
        "            if section_type_elem is not None and section_type_elem.text.upper() == \"METHODS\":\n",
        "                continue  # Skip passages under METHODS\n",
        "            # Get the full passage text.\n",
        "            passage_text_elem = passage.find(\"text\")\n",
        "            passage_text = passage_text_elem.text if passage_text_elem is not None else \"\"\n",
        "            # determine the starting offset for this passage.\n",
        "            passage_offset_elem = passage.find(\"offset\")\n",
        "            passage_offset = int(passage_offset_elem.text) if passage_offset_elem is not None else 0\n",
        "            # Split the passage into sentences using regex.\n",
        "            sentences = re.split(r'(?<=[.!?])\\s+', passage_text)\n",
        "            # Compute start indices for each sentence within the passage text.\n",
        "            start_indices = []\n",
        "            current_index = passage_offset\n",
        "            for sentence in sentences:\n",
        "                start_indices.append(current_index)\n",
        "                current_index += len(sentence) + 1  # account for the delimiter space\n",
        "\n",
        "            processed_ranges = set()  # To track which sentences have already been covered\n",
        "\n",
        "            # Process each annotation in the passage.\n",
        "            for annotation in passage.findall('annotation'):\n",
        "                ann_type = annotation.find(\"infon[@key='type']\")\n",
        "                if ann_type is not None and ann_type.text == \"Gene\":\n",
        "                    # Check for both 'identifier' and 'NCBI Gene' keys\n",
        "                    gene_id_elem = annotation.find(\"infon[@key='identifier']\")\n",
        "                    if gene_id_elem is None:\n",
        "                        gene_id_elem = annotation.find(\"infon[@key='NCBI Gene']\")\n",
        "                    gene_id = gene_id_elem.text if gene_id_elem is not None else None\n",
        "\n",
        "                    # Extract the gene name from the annotation text. (Temporary name if official name is not available)\n",
        "                    in_text_gene_name_elem = annotation.find(\"text\")\n",
        "                    in_text_gene_name = in_text_gene_name_elem.text if in_text_gene_name_elem is not None else None\n",
        "\n",
        "                    # Extract the annotation location (offset) to find the sentence containing the gene.\n",
        "                    location_elem = annotation.find(\"location\")\n",
        "                    ann_offset = int(location_elem.attrib.get('offset', 0)) if location_elem is not None else 0\n",
        "\n",
        "                    # Determine which sentence contains the annotation based on its offset.\n",
        "                    sentence_index = None\n",
        "                    for i, start in enumerate(start_indices):\n",
        "                        if start <= ann_offset < start + len(sentences[i]):\n",
        "                            sentence_index = i\n",
        "                            break\n",
        "\n",
        "                    # sentence_buffer\n",
        "                    if sentence_index is not None:\n",
        "                        start_sentence = max(0, sentence_index - 1)  # one sentence before\n",
        "                        end_sentence = min(len(sentences), sentence_index + 2)  # one sentence after\n",
        "                        range_tuple = (start_sentence, end_sentence)\n",
        "                        if range_tuple in processed_ranges:\n",
        "                            continue  # Skip duplicate extractions\n",
        "                        processed_ranges.add(range_tuple)\n",
        "                        snippet = \" \".join(sentences[start_sentence:end_sentence])\n",
        "                        if gene_id:\n",
        "                            if gene_id in gene_dict:\n",
        "                                gene_dict[gene_id].add_occurrence(snippet)\n",
        "                            else:\n",
        "                                gene_obj = Gene(gene_id)\n",
        "                                gene_obj.add_occurrence(snippet)\n",
        "                                gene_obj.set_name_from_article(in_text_gene_name)       # Temporary name if official name is not available\n",
        "                                gene_dict[gene_id] = gene_obj\n",
        "    return gene_dict\n",
        "\n",
        "def fetch_and_update_gene_info(gene_dict):\n",
        "    \"\"\"Retrieves gene information from NCBI and updates the genes in gene_dict.\"\"\"\n",
        "    gene_ids = list(gene_dict.keys())\n",
        "    if gene_ids:\n",
        "        # Post the gene IDs to NCBI.\n",
        "        handle = Entrez.epost(db=\"gene\", id=\",\".join(gene_ids))\n",
        "        result = Entrez.read(handle)\n",
        "        handle.close()\n",
        "\n",
        "        webenv = result[\"WebEnv\"]\n",
        "        query_key = result[\"QueryKey\"]\n",
        "\n",
        "        handle = Entrez.esummary(db=\"gene\", webenv=webenv, query_key=query_key)\n",
        "        record = Entrez.read(handle)\n",
        "        handle.close()\n",
        "\n",
        "        for docsum in record[\"DocumentSummarySet\"][\"DocumentSummary\"]:\n",
        "            gene_id = docsum.attributes[\"uid\"]\n",
        "            symbol = docsum.get('NomenclatureSymbol', 'No symbol')\n",
        "            organism = docsum.get('Organism', {}).get('ScientificName', 'No organism')\n",
        "            full_name = docsum.get('NomenclatureName', gene_dict[gene_id].get_name_from_article())\n",
        "            also_known_as = docsum.get('OtherAliases', gene_dict[gene_id].get_name_from_article())\n",
        "\n",
        "            # if full name and also known as are not available, use the name from the article\n",
        "            if (full_name == ''):\n",
        "                full_name = gene_dict[gene_id].get_name_from_article()\n",
        "            if (also_known_as == ''):\n",
        "                also_known_as = gene_dict[gene_id].get_name_from_article()\n",
        "\n",
        "            if gene_id in gene_dict:\n",
        "                gene_dict[gene_id].update_info(symbol, organism, full_name, also_known_as)\n",
        "            # Pause briefly to avoid overwhelming NCBI servers.\n",
        "            time.sleep(0.5)     # 2 requests per second (safe). WITH API KEY, be increased if needed to 10 requests per second.\n",
        "\n",
        "\n",
        "# Set your email (and API key if available)\n",
        "Entrez.email = \"email here\"\n",
        "# Entrez.api_key = \"your_api_key\"\n",
        "\n",
        "# example2.xml takes a while since it has 64 genes.\n",
        "xml_path = \"/content/drive/MyDrive/GOLLM/input/full_text_annotated_example2.xml\"\n",
        "gene_dict = parse_xml_file(xml_path)\n",
        "fetch_and_update_gene_info(gene_dict)           # Fetch gene information from NCBI (Optional but has good information)\n",
        "for gene in gene_dict.values():\n",
        "    print(gene)\n",
        "    print(f\"There are {len(gene.get_occurrences())} occurrences (each are AT MOST 3-setences long SO MAX of {int(3*len(gene.get_occurrences()))} sentences in total) of {gene.get_gene_id()}:{gene.get_name_from_article()}.\")\n",
        "    print(\"\")"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 4,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "UsRz3Wb5YTQl",
        "outputId": "c54aae2f-4103-4d08-f18b-29c978cd8dcb"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Extract the Gene Ontology (GO) terms for Biological Processes, Cellular Components, and Molecular Functions from the given occurrences. Use the following output format:\n",
            "Gene: <Gene Symbol or ID>\n",
            "\n",
            "Biological Processes:\n",
            "- <GO term>\n",
            "- <GO term>\n",
            "...\n",
            "\n",
            "Cellular Components:\n",
            "- <GO term>\n",
            "- <GO term>\n",
            "...\n",
            "\n",
            "Molecular Functions:\n",
            "- <GO term>\n",
            "- <GO term>\n",
            "...\n",
            "        \n",
            "Gene Context:\n",
            "\n",
            "Gene: Muscle-specific RING finger protein-1\n",
            "Occurrences:\n",
            "- In particular, atrogenes are thought to be important for protein loss. Muscle-specific RING finger protein-1 (MuRF1) is an E3 ubiquitin ligase selectively expressed in cardiac and skeletal muscles. This protein is upregulated during skeletal muscle atrophy and is able to control sarcomere muscle protein degradation.\n",
            "- The first muscle-specific ubiquitin ligases that were discovered to have a role in muscle loss were Atrogin-1/MAFbx and muscle ring finger-1 (MuRF1). Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions.\n",
            "- Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy.\n",
            "- It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy.\n",
            "- Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy. During atrophy, other E3s are produced in smaller quantities, including Trim32, a ligase important for actin, tropomyosin, and troponins degradation.\n",
            "- For example, the inhibition of some specific muscle proteins such as MAFbx or Foxo, ATF4, Gadd45a, p21, and MEKK4 transcription factors can avoid the loss of muscle mass without leading to a hypertrophic condition. Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice.\n",
            "- Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice. As an example, MG132 proteasome inhibitor can prevent muscle atrophy associated with muscle disuse.\n",
            "- Therefore, the administration of protein supplements or compounds able to stimulate protein synthesis could be useful in the prevention of atrophy. For instance, ursolic acid stimulates muscle hypertrophy and reduces the expression of MuRF-1 in soleus and extensor digitorum longus (EDL) muscle of chronic kidney disease mice. It also reduced myostatin and insulin-like growth factor-binding protein 3 (IGFBP3) in dexamethasone-treated C2C12 cell lines.\n",
            "- Identification of the MuRF1 Skeletal Muscle Ubiquitylome Through Quantitative Proteomics\n",
            "- Skeletal muscle in MuRF1 null mice is not spared in low-gravity conditions, indicating atrophy proceeds by unique mechanisms in space\n",
            "\n"
          ]
        }
      ],
      "source": [
        "def make_go_term_prompt(gene_dict, batch_size=1, batch_index=0, direct=False, customized_prompt=None):\n",
        "    \"\"\"\n",
        "    Create a prompt for Llama to output Gene Ontology (GO) terms (without IDs) for a batch of genes\n",
        "    from the gene dictionary. The output is expected to be categorized into three sections for each gene:\n",
        "      1. Biological Processes\n",
        "      2. Cellular Components\n",
        "      3. Molecular Functions\n",
        "\n",
        "    For each gene, the output should follow the format below without mixing results across different genes.\n",
        "\n",
        "    :param gene_dict: A dictionary where each key is a gene ID and each value is a Gene object that\n",
        "                      contains attributes such as symbol, organism, full_name, and occurrences.\n",
        "    :param batch_size: The number of genes to include in this prompt batch.\n",
        "    :param batch_index: The index (0-based) of the batch to process. For instance, if batch_size=1,\n",
        "                        batch_index=2 will include the 3rd gene in the dictionary.\n",
        "    :param direct: If True, use a more direct instruction for GO term extraction.\n",
        "    :param customized_prompt: If provided, use this custom prompt text in place of the default.\n",
        "    :return: A string containing the complete prompt.\n",
        "    \"\"\"\n",
        "\n",
        "    # Instruction blocks\n",
        "\n",
        "    context = \"\"\"You are an efficient and insightful assistant to a geneticist.\"\"\"\n",
        "\n",
        "    general_instructions = \"\"\"Focus on extracting the most relevant Gene Ontology (GO) terms for the following aspects:\n",
        "    1. Biological Processes\n",
        "    2. Cellular Components\n",
        "    3. Molecular Functions\"\"\"\n",
        "\n",
        "    task_instructions = \"\"\"Analyze the provided occurrences to identify and extract the most pertinent Gene Ontology (GO) terms categorized into:\n",
        "    - Biological Processes\n",
        "    - Cellular Components\n",
        "    - Molecular Functions.\"\"\"\n",
        "\n",
        "    direct_instructions = \"\"\"Extract the Gene Ontology (GO) terms for Biological Processes, Cellular Components, and Molecular Functions from the given occurrences.\n",
        "    \"\"\"\n",
        "\n",
        "    format_instructions = \"\"\"Use the following output format:\n",
        "    Gene: <Gene Symbol or ID>\n",
        "\n",
        "    Biological Processes:\n",
        "    - <GO term>\n",
        "    - <GO term>\n",
        "    ...\n",
        "\n",
        "    Cellular Components:\n",
        "    - <GO term>\n",
        "    - <GO term>\n",
        "    ...\n",
        "\n",
        "    Molecular Functions:\n",
        "    - <GO term>\n",
        "    - <GO term>\n",
        "    ...\n",
        "    \"\"\"\n",
        "\n",
        "    # Example output to illustrate the expected format\n",
        "    example_output = \"\"\" Example Output:\n",
        "\n",
        "    Gene: GFAP\n",
        "\n",
        "    Biological Processes:\n",
        "    - intermediate filament organization\n",
        "    - gene expression\n",
        "    - astrocyte development\n",
        "\n",
        "    Cellular Components:\n",
        "    - cytoplasm\n",
        "    - cell projection\n",
        "    - cell body\n",
        "\n",
        "    Molecular Functions:\n",
        "    - integrin binding\n",
        "    - kinase binding\n",
        "    - protein binding\n",
        "    \"\"\"\n",
        "\n",
        "    # Assemble the prompt text based on the chosen mode\n",
        "    if direct:\n",
        "        prompt_text = context\n",
        "        prompt_text += direct_instructions\n",
        "        prompt_text += format_instructions\n",
        "        prompt_text += example_output\n",
        "    elif customized_prompt:\n",
        "        prompt_text = context\n",
        "        prompt_text += customized_prompt\n",
        "        prompt_text += format_instructions\n",
        "        prompt_text += example_output\n",
        "    else:\n",
        "        # prompt_text = context\n",
        "        # prompt_text += task_instructions\n",
        "        # prompt_text += general_instructions\n",
        "        # prompt_text += format_instructions\n",
        "        # prompt_text += example_output\n",
        "        prompt_text = \"\"\"Extract the Gene Ontology (GO) terms for Biological Processes, Cellular Components, and Molecular Functions from the given occurrences. Use the following output format:\n",
        "Gene: <Gene Symbol or ID>\n",
        "\n",
        "Biological Processes:\n",
        "- <GO term>\n",
        "- <GO term>\n",
        "...\n",
        "\n",
        "Cellular Components:\n",
        "- <GO term>\n",
        "- <GO term>\n",
        "...\n",
        "\n",
        "Molecular Functions:\n",
        "- <GO term>\n",
        "- <GO term>\n",
        "...\n",
        "        \"\"\"\n",
        "    prompt_text += \"\\nGene Context:\\n\"\n",
        "\n",
        "    # Convert the gene dictionary to a list and determine the batch slice.\n",
        "    gene_items = list(gene_dict.items())\n",
        "    start_index = batch_index * batch_size\n",
        "    end_index = start_index + batch_size\n",
        "    batch_genes = gene_items[start_index:end_index]\n",
        "\n",
        "    # Add details and occurrence context for each gene in the selected batch.\n",
        "    for gene_id, gene_obj in batch_genes:\n",
        "        # prompt_text += f\"\\nGene ID: {gene_id}\\n\"\n",
        "        # prompt_text += f\"Symbol: {gene_obj.symbol}\\n\"\n",
        "        # prompt_text += f\"Organism: {gene_obj.organism}\\n\"\n",
        "        # prompt_text += f\"Full Name: {gene_obj.full_name}\\n\"\n",
        "        prompt_text += f\"\\nGene: {gene_obj.get_name_from_article()}\\n\"\n",
        "        prompt_text += \"Occurrences:\\n\"\n",
        "        for occ in gene_obj.occurrences:\n",
        "            prompt_text += f\"- {occ}\\n\"\n",
        "\n",
        "    return prompt_text\n",
        "\n",
        "# Example usage:\n",
        "# Assuming gene_dict is defined and contains Gene objects with attributes: symbol, organism, full_name, and occurrences.\n",
        "# To process only one gene at a time:\n",
        "# prompt = make_go_term_prompt(gene_dict, batch_size=1, batch_index=0)\n",
        "# print(prompt)\n",
        "\n",
        "prompt = make_go_term_prompt(gene_dict)\n",
        "print(prompt)"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 5,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/",
          "height": 84,
          "referenced_widgets": [
            "f863c4988bbc47038058ab5c8d0fc1bd",
            "7a1b3e913250436a86438ea9f931ac74",
            "79462973ce444dfebee8d0af3dd90296",
            "e369b21c2eda4bda916d1f6c4179c031",
            "783afc41842a470c9d4d0be862bcb4ea",
            "2fd4e0fc81fe45789847f2dfc2ee4043",
            "5ebb2e6fd16544a9943740880750f5c2",
            "451da3e0c36d4114a16445f6ed71de36",
            "52f63b5457b34844b44679a7a35bcc13",
            "73759748b33a4e38969288a3718bec61",
            "cf9cd52657494027a715105fe1be0508"
          ]
        },
        "id": "79uDpOcDIzS0",
        "outputId": "a121729c-e6ae-46d6-c95f-c4ce4964f894"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Loading LLaMA model.\n",
            "True\n"
          ]
        },
        {
          "data": {
            "application/vnd.jupyter.widget-view+json": {
              "model_id": "f863c4988bbc47038058ab5c8d0fc1bd",
              "version_major": 2,
              "version_minor": 0
            },
            "text/plain": [
              "Loading checkpoint shards:   0%|          | 0/3 [00:00<?, ?it/s]"
            ]
          },
          "metadata": {},
          "output_type": "display_data"
        }
      ],
      "source": [
        "print(\"Loading LLaMA model.\")\n",
        "# model_dir = \"/content/drive/MyDrive/Llama 3.2-3B-Instruct-model\"\n",
        "model_dir = \"/content/drive/MyDrive/GOLLM/Llama 3.2-3B-Instruct-model\"\n",
        "device = torch.device(\"cuda\")\n",
        "print(torch.cuda.is_available())\n",
        "\n",
        "tokenizer = AutoTokenizer.from_pretrained(model_dir, local_files_only=True)\n",
        "model = AutoModelForCausalLM.from_pretrained(model_dir, local_files_only=True).to(device)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 6,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "_FUGa0T-IzS0",
        "outputId": "0d0ff976-427f-40ff-b8f5-4a430b031ddb"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "\n",
            "Please analyze the following gene information and text snippets. \n",
            "Identify all potentially relevant Gene Ontology (GO) terms for each of these three categories:\n",
            "1) Biological Process\n",
            "2) Molecular Function\n",
            "3) Cellular Component\n",
            "\n",
            "For each GO term you list, include a short justification that references clues from the text. \n",
            "If you cannot identify any GO terms for a particular category, say None found.\n",
            "\n",
            "Be concise and factual. \n",
            "Avoid overly general statements like \"it is involved in many cellular processes.\"\n",
            "\n",
            "Below is an example format to illustrate how you might structure your output:\n",
            "\n",
            "Example Analysis Output\n",
            "----------------------------------------\n",
            "Biological Processes:\n",
            "- Negative regulation of cell proliferation \n",
            "  Justification: The text mentions suppressed proliferation in certain cells.\n",
            "\n",
            "Cellular Component:\n",
            "- Intermediate filament\n",
            "  Justification: The protein is described as an integral part of the cytoskeletal structure in astrocytes.\n",
            "\n",
            "Molecular Function:\n",
            "- Structural molecule activity\n",
            "  Justification: GFAP provides structural support, as indicated by references to glial fibrillary structures.\n",
            "----------------------------------------\n",
            "\n",
            "Gene Information:\n",
            "----------------------------------------\n",
            "Gene: Muscle-specific RING finger protein-1\n",
            "Occurrences:\n",
            "- In particular, atrogenes are thought to be important for protein loss. Muscle-specific RING finger protein-1 (MuRF1) is an E3 ubiquitin ligase selectively expressed in cardiac and skeletal muscles. This protein is upregulated during skeletal muscle atrophy and is able to control sarcomere muscle protein degradation.\n",
            "- The first muscle-specific ubiquitin ligases that were discovered to have a role in muscle loss were Atrogin-1/MAFbx and muscle ring finger-1 (MuRF1). Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions.\n",
            "- Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy.\n",
            "- It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy.\n",
            "- Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy. During atrophy, other E3s are produced in smaller quantities, including Trim32, a ligase important for actin, tropomyosin, and troponins degradation.\n",
            "- For example, the inhibition of some specific muscle proteins such as MAFbx or Foxo, ATF4, Gadd45a, p21, and MEKK4 transcription factors can avoid the loss of muscle mass without leading to a hypertrophic condition. Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice.\n",
            "- Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice. As an example, MG132 proteasome inhibitor can prevent muscle atrophy associated with muscle disuse.\n",
            "- Therefore, the administration of protein supplements or compounds able to stimulate protein synthesis could be useful in the prevention of atrophy. For instance, ursolic acid stimulates muscle hypertrophy and reduces the expression of MuRF-1 in soleus and extensor digitorum longus (EDL) muscle of chronic kidney disease mice. It also reduced myostatin and insulin-like growth factor-binding protein 3 (IGFBP3) in dexamethasone-treated C2C12 cell lines.\n",
            "- Identification of the MuRF1 Skeletal Muscle Ubiquitylome Through Quantitative Proteomics\n",
            "- Skeletal muscle in MuRF1 null mice is not spared in low-gravity conditions, indicating atrophy proceeds by unique mechanisms in space\n",
            "\n",
            "----------------------------------------\n",
            "\n",
            "Now, please provide a similar list of GO terms (or None found if no terms apply) under each of the three categories, with a one-line justification for each.\n",
            "\n"
          ]
        }
      ],
      "source": [
        "test_prompt = \"\"\"\n",
        "Please analyze the following gene information and text snippets.\n",
        "Identify all potentially relevant Gene Ontology (GO) terms for each of these three categories:\n",
        "1) Biological Process\n",
        "2) Molecular Function\n",
        "3) Cellular Component\n",
        "\n",
        "For each GO term you list, include a short justification that references clues from the text.\n",
        "If you cannot identify any GO terms for a particular category, say None found.\n",
        "\n",
        "Be concise and factual.\n",
        "Avoid overly general statements like \"it is involved in many cellular processes.\"\n",
        "\n",
        "Below is an example format to illustrate how you might structure your output:\n",
        "\n",
        "Example Analysis Output\n",
        "----------------------------------------\n",
        "Biological Processes:\n",
        "- Negative regulation of cell proliferation\n",
        "  Justification: The text mentions suppressed proliferation in certain cells.\n",
        "\n",
        "Cellular Component:\n",
        "- Intermediate filament\n",
        "  Justification: The protein is described as an integral part of the cytoskeletal structure in astrocytes.\n",
        "\n",
        "Molecular Function:\n",
        "- Structural molecule activity\n",
        "  Justification: GFAP provides structural support, as indicated by references to glial fibrillary structures.\n",
        "----------------------------------------\n",
        "\n",
        "Gene Information:\n",
        "----------------------------------------\n",
        "Gene: Muscle-specific RING finger protein-1\n",
        "Occurrences:\n",
        "- In particular, atrogenes are thought to be important for protein loss. Muscle-specific RING finger protein-1 (MuRF1) is an E3 ubiquitin ligase selectively expressed in cardiac and skeletal muscles. This protein is upregulated during skeletal muscle atrophy and is able to control sarcomere muscle protein degradation.\n",
        "- The first muscle-specific ubiquitin ligases that were discovered to have a role in muscle loss were Atrogin-1/MAFbx and muscle ring finger-1 (MuRF1). Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions.\n",
        "- Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy.\n",
        "- It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy.\n",
        "- Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy. During atrophy, other E3s are produced in smaller quantities, including Trim32, a ligase important for actin, tropomyosin, and troponins degradation.\n",
        "- For example, the inhibition of some specific muscle proteins such as MAFbx or Foxo, ATF4, Gadd45a, p21, and MEKK4 transcription factors can avoid the loss of muscle mass without leading to a hypertrophic condition. Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice.\n",
        "- Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice. As an example, MG132 proteasome inhibitor can prevent muscle atrophy associated with muscle disuse.\n",
        "- Therefore, the administration of protein supplements or compounds able to stimulate protein synthesis could be useful in the prevention of atrophy. For instance, ursolic acid stimulates muscle hypertrophy and reduces the expression of MuRF-1 in soleus and extensor digitorum longus (EDL) muscle of chronic kidney disease mice. It also reduced myostatin and insulin-like growth factor-binding protein 3 (IGFBP3) in dexamethasone-treated C2C12 cell lines.\n",
        "- Identification of the MuRF1 Skeletal Muscle Ubiquitylome Through Quantitative Proteomics\n",
        "- Skeletal muscle in MuRF1 null mice is not spared in low-gravity conditions, indicating atrophy proceeds by unique mechanisms in space\n",
        "\n",
        "----------------------------------------\n",
        "\n",
        "Now, please provide a similar list of GO terms (or None found if no terms apply) under each of the three categories, with a one-line justification for each.\n",
        "\"\"\"\n",
        "print(test_prompt)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 7,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "uvMhgOSVBKzY",
        "outputId": "e6e8debe-db0e-450b-888e-0af1c59e4719"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "\n",
            "Please analyze the following gene information and text snippets under \"Occurrences\". \n",
            "Identify all potentially relevant Gene Ontology (GO) terms for each of these three categories:\n",
            "1) Biological Process\n",
            "2) Molecular Function\n",
            "3) Cellular Component\n",
            "\n",
            "If you cannot identify any GO terms for a particular category, say None found.\n",
            "For each term you list, provide a short one-line explanation or justification referencing the text.\n",
            "\n",
            "Be concise and factual. \n",
            "Avoid overly general statements like \"it is involved in many cellular processes.\"\n",
            "\n",
            "Below is an example format to illustrate how you should structure your output:\n",
            "\n",
            "Example Analysis Output\n",
            "----------------------------------------\n",
            "Biological Processes (BP):\n",
            "- Negative regulation of cell proliferation\n",
            "  Justification: The text mentions suppressed proliferation in certain cells.\n",
            "\n",
            "Cellular Components (CC):\n",
            "- Intermediate filament \n",
            "  Justification: The text identifies GFAP as part of the cytoskeleton structure in astrocytes.\n",
            "\n",
            "Molecular Functions (MF):\n",
            "- Structural molecule activity\n",
            "  Justification: The text describes a role in providing structural support.\n",
            "\n",
            "----------------------------------------\n",
            "\n",
            "Gene Information:\n",
            "----------------------------------------\n",
            "Gene: Muscle-specific RING finger protein-1\n",
            "Organism: Mus musculus\n",
            "Occurrences:\n",
            "- In particular, atrogenes are thought to be important for protein loss. Muscle-specific RING finger protein-1 (MuRF1) is an E3 ubiquitin ligase selectively expressed in cardiac and skeletal muscles. This protein is upregulated during skeletal muscle atrophy and is able to control sarcomere muscle protein degradation.\n",
            "- The first muscle-specific ubiquitin ligases that were discovered to have a role in muscle loss were Atrogin-1/MAFbx and muscle ring finger-1 (MuRF1). Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions.\n",
            "- Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy.\n",
            "- It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy.\n",
            "- Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy. During atrophy, other E3s are produced in smaller quantities, including Trim32, a ligase important for actin, tropomyosin, and troponins degradation.\n",
            "- For example, the inhibition of some specific muscle proteins such as MAFbx or Foxo, ATF4, Gadd45a, p21, and MEKK4 transcription factors can avoid the loss of muscle mass without leading to a hypertrophic condition. Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice.\n",
            "- Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice. As an example, MG132 proteasome inhibitor can prevent muscle atrophy associated with muscle disuse.\n",
            "- Therefore, the administration of protein supplements or compounds able to stimulate protein synthesis could be useful in the prevention of atrophy. For instance, ursolic acid stimulates muscle hypertrophy and reduces the expression of MuRF-1 in soleus and extensor digitorum longus (EDL) muscle of chronic kidney disease mice. It also reduced myostatin and insulin-like growth factor-binding protein 3 (IGFBP3) in dexamethasone-treated C2C12 cell lines.\n",
            "- Identification of the MuRF1 Skeletal Muscle Ubiquitylome Through Quantitative Proteomics\n",
            "- Skeletal muscle in MuRF1 null mice is not spared in low-gravity conditions, indicating atrophy proceeds by unique mechanisms in space\n",
            "\n",
            "----------------------------------------\n",
            "\n",
            "Now, please only provide a similar list of GO terms (or None found if no terms apply) under each of the three categories with a brief justification for each.\n",
            "\n"
          ]
        }
      ],
      "source": [
        "test_prompt1 = \"\"\"\n",
        "Please analyze the following gene information and text snippets under \"Occurrences\".\n",
        "Identify all potentially relevant Gene Ontology (GO) terms for each of these three categories:\n",
        "1) Biological Process\n",
        "2) Molecular Function\n",
        "3) Cellular Component\n",
        "\n",
        "If you cannot identify any GO terms for a particular category, say None found.\n",
        "For each term you list, provide a short one-line explanation or justification referencing the text.\n",
        "\n",
        "Be concise and factual.\n",
        "Avoid overly general statements like \"it is involved in many cellular processes.\"\n",
        "\n",
        "Below is an example format to illustrate how you should structure your output:\n",
        "\n",
        "Example Analysis Output\n",
        "----------------------------------------\n",
        "Biological Processes (BP):\n",
        "- Negative regulation of cell proliferation\n",
        "  Justification: The text mentions suppressed proliferation in certain cells.\n",
        "\n",
        "Cellular Components (CC):\n",
        "- Intermediate filament\n",
        "  Justification: The text identifies GFAP as part of the cytoskeleton structure in astrocytes.\n",
        "\n",
        "Molecular Functions (MF):\n",
        "- Structural molecule activity\n",
        "  Justification: The text describes a role in providing structural support.\n",
        "\n",
        "----------------------------------------\n",
        "\n",
        "Gene Information:\n",
        "----------------------------------------\n",
        "Gene: Muscle-specific RING finger protein-1\n",
        "Organism: Mus musculus\n",
        "Occurrences:\n",
        "- In particular, atrogenes are thought to be important for protein loss. Muscle-specific RING finger protein-1 (MuRF1) is an E3 ubiquitin ligase selectively expressed in cardiac and skeletal muscles. This protein is upregulated during skeletal muscle atrophy and is able to control sarcomere muscle protein degradation.\n",
        "- The first muscle-specific ubiquitin ligases that were discovered to have a role in muscle loss were Atrogin-1/MAFbx and muscle ring finger-1 (MuRF1). Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions.\n",
        "- Substrates of MuRF1 are myosin heavy chains, myosin light chains, actin, myosin binding protein C, and troponin I. It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy.\n",
        "- It has been found that MuRF1 knockout mice are more resistant to muscle atrophy produced by different pathological conditions. Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy.\n",
        "- Accordingly, the MuRF1 overexpression in mice enhances ubiquitination of myofibrillar and sarcoplasmic proteins, and causes neuromuscular junction instability and muscle atrophy. However, the absence of MuRF1 does not protect soleus muscle atrophy induced by spaceflight, showing that this model is quite different with respect to other models of atrophy. During atrophy, other E3s are produced in smaller quantities, including Trim32, a ligase important for actin, tropomyosin, and troponins degradation.\n",
        "- For example, the inhibition of some specific muscle proteins such as MAFbx or Foxo, ATF4, Gadd45a, p21, and MEKK4 transcription factors can avoid the loss of muscle mass without leading to a hypertrophic condition. Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice.\n",
        "- Among the different ubiquitin ligases, MuRF1 and TRAF6 have been studied for the development of muscle-specific inhibitors. However, the removal of MuRF1 or TRAF6 only partially preserves muscle atrophy during denervation in mice. As an example, MG132 proteasome inhibitor can prevent muscle atrophy associated with muscle disuse.\n",
        "- Therefore, the administration of protein supplements or compounds able to stimulate protein synthesis could be useful in the prevention of atrophy. For instance, ursolic acid stimulates muscle hypertrophy and reduces the expression of MuRF-1 in soleus and extensor digitorum longus (EDL) muscle of chronic kidney disease mice. It also reduced myostatin and insulin-like growth factor-binding protein 3 (IGFBP3) in dexamethasone-treated C2C12 cell lines.\n",
        "- Identification of the MuRF1 Skeletal Muscle Ubiquitylome Through Quantitative Proteomics\n",
        "- Skeletal muscle in MuRF1 null mice is not spared in low-gravity conditions, indicating atrophy proceeds by unique mechanisms in space\n",
        "\n",
        "----------------------------------------\n",
        "\n",
        "Now, please only provide a similar list of GO terms (or None found if no terms apply) under each of the three categories with a brief justification for each.\n",
        "\"\"\"\n",
        "print(test_prompt1)\n"
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 8,
      "metadata": {
        "id": "YmSvGD7F2xml"
      },
      "outputs": [],
      "source": [
        "test_prompt2 = \"\"\"\n",
        "Write a critical analysis of the biological processes performed by this system of interacting proteins.\n",
        "\n",
        "Base your analysis on prior knowledge available in your training data. After completing your analysis, propose a brief and detailed name for the most prominent biological process performed by the system.\n",
        "\n",
        "After completing your analysis, please also assign a confidence level to the process name you selected. This confidence level should follow the name in parentheses and be one of the following: Low, Medium, or High. A low confidence level indicates the least confidence, while a high confidence level reflects the most confidence. This confidence level helps gauge how accurately the chosen name represents the functions and activities within the system of interacting proteins. When determining your confidence level, consider the proportion of genes in the protein system that participate in the identified biological process. For instance, if you select Ribosome biogenesis as the process name but only a few genes in the system contribute to this process, the confidence level should be low compared to a scenario where a majority of the genes are involved in Ribosome biogenesis.\n",
        "\n",
        "Put your chosen name at the top of the analysis as 'Name: <name>'.\n",
        "Put your confidence in a new line after the name as LLM self-assessed confidence: <confidence level>\n",
        "\n",
        "Be concise: Avoid unnecessary words.\n",
        "Be factual: Do not editorialize.\n",
        "Be specific: Avoid overly general statements such as the proteins are involved in various cellular processes.\n",
        "Group proteins: If group of  proteins has similar functions then discuss their interplay, synergistic, or antagonistic effects, and functional integration within the system, instead of listing facts about individual proteins\n",
        "Avoid generic process names: Choose detailed and specific names, avoiding generic names like Cellular Signaling and Regulation.\n",
        "Contextual relevance: Ensure the analysis is relevant to the specific biological context of the system of interacting proteins if provided.\n",
        "\n",
        "If you cannot identify a prominent biological process for the proteins in the system, I want you to communicate this in you analysis and name the process: \"System of unrelated proteins\". Provide a confidence of None for a \"System of unrelated proteins\".\n",
        "\n",
        "To help you in your work, I am providing an example system of interacting proteins and the corresponding example analysis output.\n",
        "\n",
        "The example system of interacting proteins is:\n",
        "PDX1, SLC2A2, NKX6-1, GLP1, GCG.\n",
        "\n",
        "The example analysis output is:\n",
        "Name: Pancreatic development and glucose homeostasis\n",
        "LLM self-assessed confidence: High\n",
        "\n",
        "1. PDX1 is a homeodomain transcription factor involved in the specification of the early pancreatic epithelium and\n",
        "its subsequent differentiation. It activates the transcription of several genes including insulin, somatostatin, glucokinase\n",
        "and glucose transporter type 2. It is essential for maintenance of the normal hormone-producing phenotype in the\n",
        "pancreatic beta-cell. In pancreatic acinar cells, forms a complex with PBX1b and MEIS2b and mediates the activation\n",
        "of the ELA1 enhancer.\n",
        "\n",
        "2. NKX6-1 is also a transcription factor involved in the development of pancreatic beta-cells during the secondary transition.\n",
        "Together with NKX2-2 and IRX3, controls the generation of motor neurons in the neural tube and belongs to the neural progenitor\n",
        "factors induced by Sonic Hedgehog (SHH) signals.\n",
        "\n",
        "3.GCG and GLP1, respectively glucagon and glucagon-like peptide 1, are involved in glucose metabolism and homeostasis.\n",
        "GCG raises blood glucose levels by promoting gluconeogenesis and is the counter regulatory hormone of Insulin.\n",
        "GLP1 is a potent stimulator of Glucose-Induced Insulin Secretion (GSIS). Plays roles in gastric motility and\n",
        "suppresses blood glucagon levels. Promotes growth of the intestinal epithelium and pancreatic islet mass both by islet\n",
        "neogenesis and islet cell proliferation.\n",
        "\n",
        "4. SLC2A2, also known as GLUT2, is a facilitative hexose transporter. In hepatocytes, it mediates bi-directional\n",
        "transport of glucose accross the plasma membranes, while in the pancreatic beta-cell, it is the main transporter responsible\n",
        "for glucose uptake and part of the cell's glucose-sensing mechanism. It is involved in glucose transport in the small intestine\n",
        "and kidney too.\n",
        "\n",
        "To summarize, the genes in this set are involved in the specification, differentiation, growth and functionality of the pancreas,\n",
        "with a particular emphasis on the pancreatic beta-cell. Particularly, the architecture of the pancreatic islet ensures proper\n",
        "glucose sensing and homeostasis via a number of different hormones and receptors that can elicit both synergistic and antagonistic\n",
        "effects in the pancreas itself and other peripheral tissues.\n",
        "\n",
        "\n",
        "Here are the interacting proteins:\n",
        "\n",
        "Proteins:\n",
        "GNG5 TBX5 ISL1 RBPJ CTNNB1 NOTCH1 SMAD4 EYA1 BMP10 SOX9 HES1 ENG MKS1 SIX1 TBX3 HAND2 PIM1 BMPR2\n",
        "\"\"\""
      ]
    },
    {
      "cell_type": "code",
      "execution_count": 9,
      "metadata": {
        "colab": {
          "base_uri": "https://localhost:8080/"
        },
        "id": "IzBYJajjYYly",
        "outputId": "6fd8be54-3895-4e79-e08d-4c5cb505f901"
      },
      "outputs": [
        {
          "name": "stdout",
          "output_type": "stream",
          "text": [
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 36.62 seconds.\n",
            "--------------------------------------------------\n",
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 35.49 seconds.\n",
            "--------------------------------------------------\n",
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 37.80 seconds.\n",
            "--------------------------------------------------\n",
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 36.92 seconds.\n",
            "--------------------------------------------------\n",
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 37.58 seconds.\n",
            "--------------------------------------------------\n",
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 37.44 seconds.\n",
            "--------------------------------------------------\n",
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 37.36 seconds.\n",
            "--------------------------------------------------\n",
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 37.28 seconds.\n",
            "--------------------------------------------------\n",
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 37.44 seconds.\n",
            "--------------------------------------------------\n",
            "Biological Process:\n",
            "- Muscle atrophy\n",
            "- Regulation of protein degradation\n",
            "- Ubiquitination\n",
            "- Response to denervation\n",
            "- Muscle disuse atrophy\n",
            "\n",
            "Justification:\n",
            "These terms are relevant to the biological processes described in the text, such as muscle loss, protein degradation, and the effects of denervation and disuse on muscle tissue. \n",
            "\n",
            "Molecular Function:\n",
            "- Ligase activity\n",
            "- Protein degradation (ubiquitin-dependent)\n",
            "- Muscle protein degradation (specific)\n",
            "- Structural support\n",
            "- Actin degradation (part of ubiquitin-dependent process)\n",
            "\n",
            "Justification: \n",
            "These terms describe the molecular functions attributed to the protein, including its role in ligating ubiquitin to target proteins, degrading muscle proteins specifically, and contributing to structural support. \n",
            "\n",
            "Cellular Component:\n",
            "- Cytoskeleton\n",
            "- Sarcomeres\n",
            "- Myofibrils\n",
            "- Sarcoplasm\n",
            "- Intermediate filaments\n",
            "- Cytoplasm\n",
            "\n",
            " Justification:\n",
            "The text mentions the involvement of\n",
            "Model loaded on cuda and it took 37.58 seconds.\n",
            "--------------------------------------------------\n"
          ]
        }
      ],
      "source": [
        "def run_inference(prompt):\n",
        "    \"\"\"\n",
        "    Run inference on the provided prompt using the specified model and tokenizer.\n",
        "\n",
        "    :param prompt: The prompt string to send to the model.\n",
        "    :return: The generated text.\n",
        "    \"\"\"\n",
        "    # Encode the prompt and move to the appropriate device\n",
        "    inputs = tokenizer(prompt, return_tensors=\"pt\").to(\"cuda\")\n",
        "    attention_mask = inputs[\"attention_mask\"]\n",
        "\n",
        "    # Greedy or minimal variation == When: You want consistent, short answers, and you dont mind if its a bit blunt.\n",
        "    # outputs = model.generate(\n",
        "    #     input_ids=inputs[\"input_ids\"],\n",
        "    #     attention_mask=attention_mask,\n",
        "    #     max_new_tokens=150,\n",
        "    #     do_sample=False,     # no sampling\n",
        "    #     num_beams=1,         # purely greedy\n",
        "    #     no_repeat_ngram_size=3,\n",
        "    #     pad_token_id=tokenizer.eos_token_id\n",
        "    # )\n",
        "\n",
        "    # Beam Search (Higher Quality / Less Randomness) == You want a more global optimum text.\n",
        "    # outputs = model.generate(\n",
        "    #     input_ids=inputs[\"input_ids\"],\n",
        "    #     attention_mask=attention_mask,\n",
        "    #     max_new_tokens=200,\n",
        "    #     do_sample=False,\n",
        "    #     num_beams=4,      # search multiple beams\n",
        "    #     length_penalty=1.0,  # see if you want to encourage or discourage long outputs\n",
        "    #     no_repeat_ngram_size=3,\n",
        "    #     pad_token_id=tokenizer.eos_token_id\n",
        "    # )\n",
        "\n",
        "    # Beam SearchV2\n",
        "    outputs = model.generate(\n",
        "        input_ids=inputs[\"input_ids\"],\n",
        "        attention_mask=attention_mask,\n",
        "        max_new_tokens=200,       # Enough tokens for a concise but thorough answer\n",
        "        do_sample=False,          # Turn off sampling; we want a more deterministic, stable answer\n",
        "        num_beams=4,              # Explore multiple beams for higher-quality completions\n",
        "        length_penalty=1.0,       # 1.0 means \"neutral\" length preference (>=1.0 encourages longer outputs)\n",
        "        no_repeat_ngram_size=3,   # Helps avoid repeating the same phrase\n",
        "        early_stopping=True,      # Stops as soon as the best beam is complete\n",
        "        pad_token_id=tokenizer.eos_token_id,\n",
        "        temperature=None,\n",
        "        top_p=None,\n",
        "    )\n",
        "    # Sampling (More Creative / Less Deterministic)\n",
        "    # outputs = model.generate(\n",
        "    #     input_ids=inputs[\"input_ids\"],\n",
        "    #     attention_mask=attention_mask,\n",
        "    #     max_new_tokens=200,\n",
        "    #     do_sample=True,       # sampling\n",
        "    #     temperature=0.7,      # moderate creativity\n",
        "    #     top_p=0.9,            # nucleus sampling\n",
        "    #     no_repeat_ngram_size=3,\n",
        "    #     pad_token_id=tokenizer.eos_token_id\n",
        "    # )\n",
        "\n",
        "    # Decode the output and return the generated text\n",
        "    generated_text = tokenizer.decode(outputs[0], skip_special_tokens=True)\n",
        "    completion = generated_text[len(prompt):].strip()\n",
        "    return completion\n",
        "\n",
        "for i in range(10):\n",
        "    start_time = time.time()\n",
        "    output = run_inference(test_prompt1)\n",
        "    print(output)\n",
        "\n",
        "    print(f\"Model loaded on {device} and it took {time.time()-start_time:.2f} seconds.\")\n",
        "    print(\"-\"*50)\n",
        "\n",
        "# prompt = \"what is 2+2\"\n",
        "# print(\"Running inference...\")\n",
        "# start_time = time.time()\n",
        "# output = run_inference(prompt)\n",
        "# print(f\"Model loaded on {device} in {time.time()-start_time:.2f} seconds.\")\n",
        "# print(output)\n"
      ]
    }
  ],
  "metadata": {
    "accelerator": "GPU",
    "colab": {
      "gpuType": "T4",
      "provenance": []
    },
    "kernelspec": {
      "display_name": "BIOIN311C1",
      "language": "python",
      "name": "python3"
    },
    "language_info": {
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "file_extension": ".py",
      "mimetype": "text/x-python",
      "name": "python",
      "nbconvert_exporter": "python",
      "pygments_lexer": "ipython3",
      "version": "3.11.11"
    },
    "widgets": {
      "application/vnd.jupyter.widget-state+json": {
        "2fd4e0fc81fe45789847f2dfc2ee4043": {
          "model_module": "@jupyter-widgets/base",
          "model_module_version": "1.2.0",
          "model_name": "LayoutModel",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "451da3e0c36d4114a16445f6ed71de36": {
          "model_module": "@jupyter-widgets/base",
          "model_module_version": "1.2.0",
          "model_name": "LayoutModel",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "52f63b5457b34844b44679a7a35bcc13": {
          "model_module": "@jupyter-widgets/controls",
          "model_module_version": "1.5.0",
          "model_name": "ProgressStyleModel",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "ProgressStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "bar_color": null,
            "description_width": ""
          }
        },
        "5ebb2e6fd16544a9943740880750f5c2": {
          "model_module": "@jupyter-widgets/controls",
          "model_module_version": "1.5.0",
          "model_name": "DescriptionStyleModel",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "73759748b33a4e38969288a3718bec61": {
          "model_module": "@jupyter-widgets/base",
          "model_module_version": "1.2.0",
          "model_name": "LayoutModel",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "783afc41842a470c9d4d0be862bcb4ea": {
          "model_module": "@jupyter-widgets/base",
          "model_module_version": "1.2.0",
          "model_name": "LayoutModel",
          "state": {
            "_model_module": "@jupyter-widgets/base",
            "_model_module_version": "1.2.0",
            "_model_name": "LayoutModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "LayoutView",
            "align_content": null,
            "align_items": null,
            "align_self": null,
            "border": null,
            "bottom": null,
            "display": null,
            "flex": null,
            "flex_flow": null,
            "grid_area": null,
            "grid_auto_columns": null,
            "grid_auto_flow": null,
            "grid_auto_rows": null,
            "grid_column": null,
            "grid_gap": null,
            "grid_row": null,
            "grid_template_areas": null,
            "grid_template_columns": null,
            "grid_template_rows": null,
            "height": null,
            "justify_content": null,
            "justify_items": null,
            "left": null,
            "margin": null,
            "max_height": null,
            "max_width": null,
            "min_height": null,
            "min_width": null,
            "object_fit": null,
            "object_position": null,
            "order": null,
            "overflow": null,
            "overflow_x": null,
            "overflow_y": null,
            "padding": null,
            "right": null,
            "top": null,
            "visibility": null,
            "width": null
          }
        },
        "79462973ce444dfebee8d0af3dd90296": {
          "model_module": "@jupyter-widgets/controls",
          "model_module_version": "1.5.0",
          "model_name": "FloatProgressModel",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "FloatProgressModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "ProgressView",
            "bar_style": "success",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_451da3e0c36d4114a16445f6ed71de36",
            "max": 3,
            "min": 0,
            "orientation": "horizontal",
            "style": "IPY_MODEL_52f63b5457b34844b44679a7a35bcc13",
            "value": 3
          }
        },
        "7a1b3e913250436a86438ea9f931ac74": {
          "model_module": "@jupyter-widgets/controls",
          "model_module_version": "1.5.0",
          "model_name": "HTMLModel",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_2fd4e0fc81fe45789847f2dfc2ee4043",
            "placeholder": "",
            "style": "IPY_MODEL_5ebb2e6fd16544a9943740880750f5c2",
            "value": "Loadingcheckpointshards:100%"
          }
        },
        "cf9cd52657494027a715105fe1be0508": {
          "model_module": "@jupyter-widgets/controls",
          "model_module_version": "1.5.0",
          "model_name": "DescriptionStyleModel",
          "state": {
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "DescriptionStyleModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/base",
            "_view_module_version": "1.2.0",
            "_view_name": "StyleView",
            "description_width": ""
          }
        },
        "e369b21c2eda4bda916d1f6c4179c031": {
          "model_module": "@jupyter-widgets/controls",
          "model_module_version": "1.5.0",
          "model_name": "HTMLModel",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HTMLModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HTMLView",
            "description": "",
            "description_tooltip": null,
            "layout": "IPY_MODEL_73759748b33a4e38969288a3718bec61",
            "placeholder": "",
            "style": "IPY_MODEL_cf9cd52657494027a715105fe1be0508",
            "value": "3/3[00:03&lt;00:00,1.02it/s]"
          }
        },
        "f863c4988bbc47038058ab5c8d0fc1bd": {
          "model_module": "@jupyter-widgets/controls",
          "model_module_version": "1.5.0",
          "model_name": "HBoxModel",
          "state": {
            "_dom_classes": [],
            "_model_module": "@jupyter-widgets/controls",
            "_model_module_version": "1.5.0",
            "_model_name": "HBoxModel",
            "_view_count": null,
            "_view_module": "@jupyter-widgets/controls",
            "_view_module_version": "1.5.0",
            "_view_name": "HBoxView",
            "box_style": "",
            "children": [
              "IPY_MODEL_7a1b3e913250436a86438ea9f931ac74",
              "IPY_MODEL_79462973ce444dfebee8d0af3dd90296",
              "IPY_MODEL_e369b21c2eda4bda916d1f6c4179c031"
            ],
            "layout": "IPY_MODEL_783afc41842a470c9d4d0be862bcb4ea"
          }
        }
      }
    }
  },
  "nbformat": 4,
  "nbformat_minor": 0
}
